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ABSTRACT

MOLECULAR INSIGHTS INTO THE DISTINCT MECHANISMS REGULATING
THE TLR4 MEDIATED ACTIVATION, SHUT DOWN, AND ENDOTOXIN
TOLERANCE OF IL1B AND TNF

By
Juraj Adamik
May 2013

Dissertation supervised by Philip. E. Auron, Ph.D.
The first wave of the inducible gene network up-regulated by pathogen-stimulated
mononuclear cells encodes a variety of effector proteins with pleitropic biological
activities. This class of primary immediate early (IE) genes codes for potent proinflammatory cytokines and chemokines that play a prominent role during the
manifestation of inflammatory response. In an attempt to better understand induction
mechanisms for such genes, I have focused on those coding for human interleukin-1
(IL1B) and tumor necrosis factor  (TNF), which exhibit both transient IE induction as
well as cell-type restriction. Employing a combined approach using cell lines and primary
cells,

reporter

transient

transfection,

chromatin

conformational

capture

and

immunoprecipitation, evaluation of transcript integrity, ectopic expression in a noncompetent cell type, and comparison to mouse orthologs, I have determined that a
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complex array of mechanisms interplay in order to distinctly regulate the Toll-like
receptor (TLR) signaling-dependent induction of these two important pro-inflammatory
genes whose deregulation provides the etiology for numerous diseases. Prior to induction,
TNF exhibited pre-bound TATA Binding Protein (TBP) and paused RNA Polymerase II
(Pol II), which are the hallmarks of poised IE genes. In contrast, IL1B is stringently
regulated by long-distance chromosome gyrations, multistep activation through a unique
doubly-paused Pol II which, in association with the monocyte lineage factor Spi1/PU.1
(Spi1), maintains a low TBP and Pol II occupancy prior to activation. Activation and
DNA binding of the transcription factors C/EBP and NF-B resulted in de novo
recruitment of TBP and Pol II to IL1B in concert with a permissive state for elongation
mediated by the recruitment of the positive elongation factor b (P-TEFb). This Spi1dependent mechanism for IL1B transcription, which is unique for a rapidlyinduced/poised IE gene, was more dependent upon P-TEFb than was the case for the
TNF gene. Nucleosome occupancy and chromatin modification analyses of the IL1B and
TNF promoters, revealed activation-specific changes in chromatin marks that are
supportive for nucleosome clearance and formation of nucleosome free regions (NFR).
Furthermore, ectopic expression of Spi1, along with a TLR surrogate (over-expressed
TNF receptor associated factor 6, TRAF6), in a cell line incompetent for IL1B
transcription, is observed to prime the cell’s endogenous genome for IL1B induction by
appropriately phasing promoter nucleosomes and recruiting paused Pol II in a manner
reminiscent of that observed in competent monocytes. Here I report a novel connection
between the metabolic state of cells and HIF-1 in regulating murine Il1b gene
expression. With regard to the lipopolysaccharide (LPS) unresponsive state known as

v

endotoxin tolerance, my data revealed that following transient induction, IL1B and TNF
remained marked with paused Pol II complexes for up to 24 hours post-stimulation. Upon
subsequent LPS exposure, tolerized TNF remained in an unresponsive paused state, while
IL1B resumed transcription due to recruitment of positive elongation kinase P-TEFb.
Emerging evidence suggests that inflammatory responses of LPS/TLR4 activated
macrophages are interconnected with metabolic pathways, resulting in the shift of energy
utilization by the cells. Here I report that inhibition of either phosphoinositide 3-kinase
(PI3K) or glucose metabolism had a greater affect on the transcriptional response of Il1b
than of Tnf. The differences between these two genes, especially for endotoxin tolerance,
suggest that il1b may play a distinct role from tnf in chronic inflammation.

vi

ACKNOWLEDGEMENTS

First of all I would like to express my sincere gratitude to my advisor Dr. Philip E.
Auron for sharing his knowledge, guidance, enthusiasm, and continuous support
throughout my graduate studies. It was my privilege to learn and work under his
supervision and be a part of his research group. I would like to express my appreciation to
my dissertation committee members, Dr. Karen Arndt, Dr. Rita Mihailescu, and Dr. Joseph

R. McCormick for their insightful advice, critique, and discussions during our meetings
and generation of this dissertation work. Many thanks go to the staff in the Dean’s office
and the faculty, staff, and graduate students in the Department of Biological Sciences for
their help and friendships. I also thank my former and current lab colleagues An-Jey A. Su

and Dr. Kent Z. Q. Wang for their great collaboration, support, and contributions to my
research.
The journey in the Auron Lab was quite an experience in getting to know the world
of molecular biology. I had the opportunity to attend and present my research in several

conferences in the US and Europe (The American Society For Biochemistry and
Molecular Biology (ASBMB) 2009-2012, Cytokine 2010, The IL-1 Family of Cytokines
2011, IL-1 Family Members and the Inflammasome 2012, Pittsburgh Science 2012),
which greatly enhanced my scientific advancement and provided opportunity to meet
with international collaborators. I would like to thank my collaborators Dr. Deborah L.
Galson, Dr. Luke O’ Neill, Dr. Gillian Tannahill, Dr. Tripp Barrie, and Mathew Henkel
for their support and valuable scientific interactions. In addition to my dissertation
project, I have expanded my research experience by studying the role of HIF-1α during
the metabolic shift of LPS activated bone marrow derived macrophages in a collaborative
vii

effort with the laboratory of professor Luke O’ Neill at Trinity college of Dublin, which
has resulted in recent acceptance of a publication in the journal Nature entitled
“Succinate is a danger signal from mitochondria that induces IL-1β transcription via HIF1α”. My second collaboration with the laboratory of Dr. Tripp Barrie at the University of
Pittsburgh ventured into the world of the regulation of the IL17A and IL17F genes in
primary Th17 cells.
There is a long list of acknowledgements among my mentors and friends who have
provided me with support over the years and helped me to obtain solid foundations for my
achievements. I will not be able to acknowledge them here individually.
The last but certainly not the least, I would like to dedicate my dissertation to my
families in Slovakia, parents Adriena and Marek, grandparents Anna, Adela, Anton, and
Stefan and my brothers Marek and Danny, as well as in United States parents Linda, Duane,
brothers Jonny and Chris, his wife Anina, and grandfather Jim. You have provided me with
love, understanding, and support that have been carried through my studies and preparation
of this work.

viii

TABLE OF CONTENTS
Page
Abstract ...................................................................................................................... iv-vi
Acknowledgement .................................................................................................. vii-viii
List of Tables .................................................................................................................. x
List of Figures ........................................................................................................... xi-xv
Abbreviations ....................................................................................................... xvi-xvii
Introduction ..................................................................................................................... 1
Hypothesis and Specific Aims ....................................................................................... 26
Materials and Methods .................................................................................................. 29
Results .......................................................................................................................... 42
Discussion ................................................................................................................... 118
Summary of Novel Findings and Future Studies .......................................................... 141
References Cited ......................................................................................................... 146
Appendices ................................................................................................................. 161

ix

LIST OF TABLES
Page
Table 1. Antibodies used for ChIP and Western Blot Analyses ..................................... 33
Table 2. Human IL1B ChIP primer sequences............................................................... 34
Table 3. Human TNF ChIP primer sequences ............................................................... 35
Table 4. Human JUNB and HIST1H4K ChIP primer sequences .................................... 36
Table 5. Murine Il1b and Tnf ChIP primer sequences ................................................... 37
Table 6. mRNA analyses and qPCR primer sequences ................................................... 39
Table 7. Site-directed mutagenesis primer pairs ............................................................. 41

x

LIST OF FIGURES
Page
Figure 1. The TLR4 meditated activation of NF-B and C/EBPβ .................................... 6
Figure 2. Illustration of the paused Pol II dynamics and chromatin landscape along a
typical gene ................................................................................................................... 11
Figure 3. Depiction of the IL1B gene regulatory region ................................................. 17
Figure 4. IL-1 family gene cluster on the long arm of chromosome 2 ....................... 20-21
Figure 5. Glucose metabolism and regulation of HIF-1 ............................................... 25
Figure 6. IL1B and TNF expression in LPS stimulated THP-1 cells ............................... 42
Figure 7. Comparison of IL1B and TNF Transcription in Monocytes ............................. 43
Figure 8. Analysis of IL1B and TNF mRNA splicing efficiency and expression kinetics in
resting and stimulated THP-1 monocytes ....................................................................... 44
Figure 9. Un-spliced TNF transcripts in LPS treated THP-1 cells and hPBMC ......... 45-46
Figure 10. Schematic representation of ChIP-qPCR amplicons and generation of the data
profiles for resting (0h), 1h, and 5h LPS treated THP-1 cells .................................... 47-48
Figure 11. Pol II occupancy at the il1b and tnf loci ........................................................ 49
Figure 12. Kinetic ChIP analysis of Pol II recruitment to the IL1B and TNF gene
promoters ................................................................................................................... 50
Figure 13. TNF expression is desensitized in THP-1 cells .............................................. 51
Figure 14. Low resolution ChIP profiles for IL1B and TNF ........................................... 53
Figure 15. High-density qPCR-ChIP amplicons encompassing the promoters of the IL1B
and TNF genes .............................................................................................................. 54
Figure 16. Analysis of the chromatin fragmentation....................................................... 54

xi

Page
Figure 17. Distribution of factors relevant to differential transcriptional regulation ... 56-57
Figure 18. ChIP analysis for Pol II enrichment at control genes JUNB and HIST1H4K .. 58
Figure 19. Average profiles of factors relevant to differential transcriptional regulation in
LPS-treated RAW264.7 cells .................................................................................... 61-62
Figure 20. Average profiles of various factors relevant to differential transcriptional
regulation in ex vivo-differentiated LPS-treated BMDM ................................................ 63
Figure 21. Analysis of promoter proximal qPCR amplicon efficiency ............................ 65
Figure 22. Steady-state mRNA kinetics for IL1B, TNF, and control gene transcripts in
LPS stimulated THP-1 cells ...................................................................................... 66-67
Figure 23. Western blot depiction of the 30 KDa proIL-1 precursor protein ................. 68
Figure 24. ChIP re-stimulation experiments at 25 hours ............................................ 70-71
Figure 25. ChIP re-stimulation experiments at 13 hours................................................. 72
Figure 26. qPCR-amplified random primer generated cDNA levels for IL1B and TNF
following re-stimulation ................................................................................................ 73
Figure 27. Washing of cells prior to re-stimulation abolishes IL1B expression ............... 74
Figure 28. Nucleosome positioning dynamics during IL1B and TNF induction ......... 76-77
Figure 29. Nucleosome eviction at the IL1B and TNF promoter regions is likely mediated
by the ATP-dependent histone remodeler SNF2/BRG1 ............................................... 79
Figure 30. Histone modifications at IL1B and TNF in THP-1, Hut102, and HEK 293 cells
................................................................................................................................. 80-81
Figure 31. Spatial-temporal distribution of H3K4me1 at IL1B and TNF in THP-1 cells 83
Figure 32. ChIP analysis of p300 association at the IL1B and TNF genes ...................... 84

xii

Page
Figure 33. Summary of the histone modification ChIP profiles for IL1B and TNF in THP1, HEK 293, Hut102, and MG63 cells ...................................................................... 85-86
Figure 34. ChIP analysis of Spi1 binding to the IL1B promoter and enhancer regions .... 88
Figure 35. RT-PCR analysis of the transcription factor expression levels in HEK293 cells
...................................................................................................................................... 89
Figure 36. Spi1 is critical for IL1BXT-Luc reporter activity in HEK293 cells ................ 90
Figure 37. Ectopically transfected transcription factors induce endogenous IL1B
expression in HEK 293 cells .......................................................................................... 91
Figure 38. Spi1, IRF8, and TRAF6 induce endogenous IL1B mRNA levels in HEK293
cells ............................................................................................................................... 91
Figure 39. Spi1 does not affect the endogenous levels of TNF mRNA in HEK293 cells 92
Figure 40. Detection of ectopically expressed Spi1 mRNA in HEK293 cells ................. 92
Figure 41. The N-terminal domain of Spi1 is critical for the recruitment of TBP and Pol
II to the endogenous IL1B promoter in HEK293 cells .................................................... 94
Figure 42. Spi1, co-transfected with IRF8 and TRAF6, mediates nucleosome eviction
from the IL1B gene promoter......................................................................................... 95
Figure 43. Kinetic binding of NF-B to IL1B and TNF in THP-1 cells .......................... 96
Figure 44. NF-B is necessary for the LPS induction of IL1B and TNF genes in THP-1
cells ............................................................................................................................... 97
Figure 45. LPS inducible binding of C/EBP to IL1B in THP-1 cells ............................ 98
Figure 46. C/EBP inhibition decreases IL1B mRNA expression in RAW264.7 cells .... 98

xiii

Page
Figure 47. The effects of NF-B and C/EBP inhibition on IL1B and TNF mRNA
expression in RAW264.7 and THP-1 cells ..................................................................... 99
Figure 48. NF-B and C/EBP cooperatively induce ILBXT-Luc activity ..................... 99
Figure 49. Inhibition of NF-B activity does not completely abolish IL1BXT-Luc activity
.................................................................................................................................... 100
Figure 50. Ectopic transfection of dnC/EBP abolishes IL1BXT-Luc reporter activity in
HEK293 ...................................................................................................................... 101
Figure 51. Mutation of the critical C/EBP and NF-B binding sites reduces IL1BXTLuc reporter activity .................................................................................................... 102
Figure 52. siRNA mediated inhibition of C/EBP, NF-B, and Spi1 reduced IL1BXTLuc reporter activity in HEK293.................................................................................. 102
Figure 53. Effect of various inhibitors on P-TEFb binding to IL1B and TNF in THP-1
cells ............................................................................................................................. 104
Figure 54. The effect of inhibitors on BRD4 binding to IL1B and TNF in THP-1 cells. 104
Figure 55. DRB differentially affects the S2P CTD Pol II occupancy on IL1B and TNF
genes THP-1 cells ....................................................................................................... 105
Figure 56. H3K4me1 is present throughout IL1B and TNF in THP-1 cells ................... 106
Figure 57. LPS induced chromatin looping regulates IL1B expression .................. 107-108
Figure 58. Effects of U0126 and MG132 on Pol II ChIP for IL1B and TNF ................. 109
Figure 59. The effect of PI3K inhibition on P-TEFb recruitment to Il1b in RAW264.7
cells.................................................... ........................................................................... 110

xiv

Page
Figure 60. Distinct metabolic sensitivity for transcription elongation on Il1b and Tnf in
murine bone marrow-derived monocytes .............................................................. 112-113
Figure 61. A schematic representation of putative HIF1 binding site upstream of the
il1b gene promoter ...................................................................................................... 114
Figure 62. HIF-1 is recruited to the Il1b and Tlr4 genes in LPS treated BMDM ........ 115
Figure 63. Coordinate expression of the IL-1 gene family members...................... 116-117
Figure 64. Metabolic and TLR4 dependent pathways differentially regulate transcription
of il1b and tnf ....................................................................................................... 126-127
Figure 65. Model depicting a possible special configuration for the IL1B promoter
sequence ...................................................................................................................... 135
Figure 66. Proposed Mechanism for LPS mediated induction of IL1B and TNF in
monocytes ............................................................................................................ 138-140

xv

ABBREVIATIONS
-KG ........................................................................................................ -ketoglutarate
Bp .................................................................................................................. base pair (s)
C/EBPβ ..................................................................... CCAAT/enhancer-binding protein β
ChIP ................................................................................ chromatin immuno precipitation
CTD ........................................................................................... carboxy terminal domain
DNA ............................................................................................... deoxyribonucleic acid
HRE ......................................................................................... hypoxia-response element
HIF-1 ....................................................................................... hypoxia induced factor 
H3 ....................................................................................................................... histone 3
IE ............................................................................................................. immediate early
IL1B ....................................................................................... human Interleukin-1 gene
Il1b ......................................................................................... murine Interleukin-1 gene
il1b ............................................... indicates both, human and murine Interleukin-1 gene
IRF8 ..................................................................................... Interferon regulatory factor 8
LPS ..................................................................................................... lipopolysaccharide
mRNA..................................................................................... messenger ribonucleic acid
NELF ....................................................................................... Negative elongation factor
NF-B .................................................................................... nuclear factor (NF)-kappaB
NFR .............................................................................................. nucleosome free region
PAMPs ................................................................. pathogen-associated molecular patterns
Pol II ................................................................................................. RNA Polymerase II
PRRs ..................................................................................... pattern recognition receptors
xvi

P-TEFb .................................................................................. Positive elongation factor b
qPCR..................................................................... quantitative polymerase chain reaction
S2P ............................................................................................. serine 2 phosphorylation
S5P ............................................................................................. serine 5 phosphorylation
TBP................................................................................................ TATA binding protein
TLR4.................................................................................................. Toll-like Receptor 4
TNF .......................................................................... human Tumor necrosis factor  gene
Tnf .......................................................................... murine Tumor necrosis factor  gene
tnf .................................. indicates both, human and murine Tumor necrosis factor  gene
2-DG ........................................................................................................ 2-deoxyglucose

xvii

INTRODUCTION
Innate Immune System, Toll-like Receptors and LPS Sensing
The immune system is an integrative network of organs, cells and defensive
molecules capable of mounting protective responses against invading microorganisms.
The evolution of vertebrate immunity was driven by a continuous challenge from the
external environment mediated by interactions with a surrounding microbial world. Such
homeostasis between the host organism and pathogens provided a framework for the
expansion of various defense mechanisms, which are inherently tuned to distinguish and
eliminate the microbial pathogens (Iwasaki and Medzhitov, 2010). However not all
microbes are harmful. Adaptation of the immune system also led to the development of a
symbiotic homeostasis with the various types of microorganisms. Enterobacteria residing
within selective segments of the vertebrate digestive tract are an example of a symbiotic
relationship. A specialized branch of the immune system associated with fostering gut
microbes has evolved to maintain their metabolic benefits to the host (Hooper et al.,
2012). In addition to the recognition of foreign substances, immune-surveillance is also
primed to detect various features associated with physiologically altered cancerous and/or
virus-infected host cells.
Innate immunity, as the first line of host defense, consists of a series of
anatomical, physiological and phagocytic barriers. These mechanisms are present prior to
the onset of infection in order to effectively initiate a set of rapid responses mediating the
clearance of pathogens.

When activated, components of the innate immune system

trigger the adaptive defense mechanisms consisting of the T cell and B cell mediated
responses (Akira et al., 2001). The hallmarks of acquired immunity include the high
1

specificity against a diverse set of antigens, immunologic memory and the prevention
from initiating detrimental autoimmune responses. The integration of the innate and
adaptive branches during the immune response results in a precise recognition of the
invading pathogen, its effective clearance, and a build up of long-term memory against it,
enabling a protection during the subsequent exposures.
The hallmark of the innate immune defense involves a set of protective
mechanisms activated during tissue injury collectively known as the inflammatory
response, which provides “non-specific” destruction of microbes and prevents the
spreading of infection throughout a host organism. Initiation of this response requires a
detection of microbial components by phagocytic cells such as neutrophils, monocytes
and macrophages. Upon the recognition of pro-inflammatory, metabolic or immune
stimuli, monocytes, comprising 10% of leukocytes in blood (Auffray et al., 2009),
migrate into various anatomical locations where they differentiate into various types of
macrophages and dendritic cells. The specific microenvironments within the peripheral
tissues induce specialization of the individual macrophages into various sub-populations.
These include the interstitial and alveolar macrophages (lungs), Kupffer cells (liver),
Langerhan cells (skin), pleural and peritoneal macrophages (serous cavities), microglial
cells (brain), and osteoclasts (bone) (Auwerx, 1991; Gordon and Taylor, 2005). These
scavenger phagocytes detect the conserved metabolites unique to the microbial world,
known as the pathogen-associated molecular patterns (PAMPs), by means of distinct
types of pattern recognition receptors (PRRs) situated on their membrane surface as well
as within the intracellular compartments. These receptor sensors and their associated
signaling pathways are evolutionarily conserved throughout the animal and plant
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kingdoms (O'Neill, 2011). PAMPs (LPS, flagellin, bacterial and viral unmethylated CpG
DNA, to name few) are constitutively expressed metabolic products that are central to
microbial survival. Since they are highly conserved among the different classes of
microbes, the innate immune system evolved various mechanisms to specifically target
these molecular patterns (Medzhitov, 2001). The continuously scavenging PRRs are also
responsive to a variety of common endogenous products that are abnormally released
from damaged tissues and necrotic cells, commonly known as the “Damage or Danger”
associated molecular patterns (DAMPs). For instance the heat shock proteins, uric acid,
ATP, defensins, and HMGB1, are released from dying cells that are harmed during
common tissue injury, or by the effects of catalytic enzymes and reactive nitric oxide
species released non-specifically from the surrounded inflamed areas (Bianchi, 2007;
Kono and Rock, 2008).
Short-term effects of the inflammation controlling the protection and healing
activities associated with tissue damage have beneficial effects. However the sites of
infection or injury can also lead to the chronic (long-term) inflammatory responses that
are the basis for the etiology of numerous diseases. Emerging evidence also suggests that
inflammation can contribute to cancerous malignancies, due to a presence of various
proliferative growth factors and stimulatory molecules that are vastly present in the
inflamed tissues. In addition, the use of various receptors and adhesion molecules utilized
by the spreading metastatic cells closely resemble the mechanisms associated with a
tissue invasion of inflammatory cells (Coussens and Werb, 2002).
The toll-like receptors (TLR) are a super-family of germ-line encoded PRRs,
found in plants, invertebrates, and mammals, which are known to recognize the diverse
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classes of bacterial, fungal and microbial components (Armant and Fenton, 2002). Initial
studies of a Drosophila melanogaster plasma membrane protein, Toll, led to the
identification of a highly conserved family of ten human and twelve murine TLRs
(Takeda and Akira, 2005). Each member of the TLR family can recognize distinct classes
of molecules that are unique to microbes. In addition, these membrane receptors can form
dimers and expand their scavenger potential. For instance the heterodimeric combinations
TLR2/TLR1 and TLR2/TLR6 recognize extracellular lipopeptides and lipoproteins that
are part of the bacterial cell walls. On the other hand TLR members 3, 7, 8, and 9 are
strategically positioned within the intracellular compartments recognizing single and
double stranded microbial nucleic acids (Kang and Lee, 2011). Lipopolysaccharide (LPS)
is a unique component of gram-negative bacterial cell walls recognized by the family
member TLR4, which is present at the cell surface of monocytes and various tissue
macrophages. Binding of this endotoxin to the receptor transduces information from the
cell surface to the cytoplasm where it stimulates a cascade of events involving various
cytoplasmic factors, many of which are pre-made in the resting cells. During the final
steps of signaling, protein kinase cascades and various enzymes converge and modify
(for instance by phosphorylation, or ubiquitylation) the inactive transcription factors and
their regulators residing within the cytoplasm. The altered/activated transcription factors
can then translocate to the nucleus where they act as transcription activators and/or
repressors affecting the induction of specific genes.
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NF-B and C/EBPβ
A classical example of sub-cellular sequestration is represented by the nuclear
factor (NF)-kappaB (NF-B) family of transcription factors, which are complexed with
IB inhibitor proteins. In resting monocytes, the latent NF-B residing in the cytoplasm
is bound by a member of the inhibitory IB family of proteins. TLR4 stimulation
activates IKK kinase (via ubiquitin ligase TRAF6), which phosphorylates IB. This
modification causes IKK degradation and the subsequent release of the active form of
NF-B, which translocates to the nucleus (Chen and Greene, 2004). Figure 1 illustrates
this TRAF6 mediated activation pathway. The NF-B family of proteins consists of the
“NF-B” proteins (NF-B1 and NF-B2) and the three “Rel” subfamily proteins (RelA
(p65), RelB and c-Rel). Initially translated as long precursors, NF-B1 (p105) and NFB2 (p100) are cleaved into functional transcription factors p50 and p52, respectively
(Radisky and Bissell, 2007). These two precursor members possess an extended Cterminal IB-like domain, which facilitates their auto-inhibition and cytoplasmic
retention (Kawai and Akira, 2007). RelA (p65), RelB and c-Rel do not require proteolytic
processing for activation. In contrast to NF-B1 and NF-B2, the C-terminal portion of
the Rel members contains a transactivation domain (TAD), which supports gene
activation. A highly conserved Rel-homology domain (RHD) is a shared feature among
all family members. This domain mediates DNA binding as well as dimerization among
the family members (Gilmore, 2006).

5

Figure1. The TLR4 meditated activation of NF-B and C/EBPβ.
LPS binding causes the transmembrane pattern recognition receptor TLR4 to convey the activation signal
into the cytoplasm through the signaling molecule TRAF6. Represented are two distinct signaling pathways
downstream of TRAF6, which involve a cascade of adaptor proteins that activate transcription factors
NF-B and C/EBPβ. Shown are the target sites for inhibitors MG132 (NF-B) and U0126 (C/EBPβ) used
in this study. While MG132 blocks IKK induced proteosome degradation of the inhibitory IB protein,
U0126 strongly blocks the activation of ERK/MAPK phosphorylation pathway, and to a lesser degree the
hyper-activation of NF-B p65.
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The most prominent form of activated NF-B during TLR4 mediated signaling is
a heterodimeric complex p65/p50 (Kawai and Akira, 2007). Upon translocation to the
nucleus, the activated dimer binds to DNA sequences located within the regulatory
regions of numerous pro-inflammatory genes and influences their transcription (Radisky
and Bissell, 2007). An additional regulatory layer associated with NF-B mediated
transcriptional activation resides within its TAD. The NF-B p65 TAD was shown to
associate with the general transcription factor TATA-binding protein (TBP), transcription
factor IIB (TFIIB) as well as the coactivators histone acetyl transferase (HAT) p300 and
cyclic-AMP-response element (CREB) binding protein (CBP) (Chen and Greene, 2004).
Deregulation of NF-B signaling is often associated with the etiology of various forms of
inflammatory diseases and malignancies due to its pleiotropic effects influencing several
aspects of cell physiology, such as apoptosis and proliferation (Naugler and Karin, 2008).
The CCAAT/enhancer-binding protein (C/EBP) family of basic leucine zipper
(bZIP) transcription factors plays an important role in regulating gene expression during
immune responses, proliferation, and cell differentiation. The six members of C/EBP
family include C/EBPα, C/EBPβ, C/EBPγ, C/EBPδ, C/EBPε and C/EBPδ. While
C/EBPα, C/EBPβ and C/EBPγ are virtually universally expressed, the others are either
inducible (C/EBPδ), or their expression is confined to selected cell types of the
hematopoietic system (C/EBPε) (Johnson, 2005). LPS signaling in monoctyes initiates
several mitogen activated protein kinase (MAPK) pathways, which ultimately converge
to activate C/EBPβ. Both, the DNA binding and homotypic dimerization domains of the
C/EBP members are confined to their C-terminal bZIP domain. This highly conserved
basic DNA binding module also functions as the nuclear localization signal. The amino
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terminal portion of C/EBPβ contains the TAD, as well as a signal-responsive regulatory
domain (Johnson, 2005; Tsukada et al., 2011). Figure 1 depicts the activation of C/EBPβ
during the TLR4 signaling pathway, initiated by the small GTPase Ras. This mediator
induces c-Raf and stimulates the MEK1/ERK1 transduction cascade to phosphorylate
C/EBPβ, which undergoes a conformational change (Guha and Mackman, 2001). The
inducible activation of C/EBPβ plays an important role in triggering the expression of
various cytokines during the inflammatory response and genes controlling the acutephase response and differentiation of hematopoietic cells (Tsukada et al., 2011). In
addition to interacting with transcription factors such as c-Myb (Tsukada et al., 2011),
C/EBPβ can synergistically interact with the chromatin remodeling SWI/SNF complexes
(Kowenz-Leutz and Leutz, 1999), as well as transcriptional coactivators such as HATs,
CBP and p300. These protein associations induce gene expression by promoting
transcription permissive histone modifications (acetylation), nucleosome remodeling and
the recruitment of general transcription factors to gene promoters (Kovacs et al., 2003).

Monocyte/Macrophage Gene Networks, Nucleosome Positioning and Pol II Pausing
LPS-stimulated monocytes activate distinctive sets of genes responsible for the
initiation of appropriate immune-physiological responses that are characteristic for these
cells. These gene networks are activated sequentially in a time dependent fashion,
producing waves of immediate-early, early, and late gene transcription. For instance, the
pathogen activated dendritic cells (DCs) rapidly repress genes associated with
phagocytosis and pathogen recognition. At the same time these cells up-regulate the
transcription of genes encoding immune products responsible for the recruitment of
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monocytes, DCs, and macrophages to infected body areas (Huang et al., 2001).
The first wave of the inducible gene network up-regulated by pathogen-stimulated
mononuclear cells encodes a variety of effector proteins with pleitropic biological
activities. This class of primary immediate early (IE) genes codes for potent proinflammatory cytokines and chemokines that play a prominent role during the
manifestation of the inflammatory response. The transcription of these genes is highly
regulated, as their products are associated with potent immune-stimulatory and cytotoxic
properties. Locally they can induce vasodilation by altering endothelial cells and
stimulate recruitment of neutrophils and macrophages to the site of infection.
Additionally, they mediate various systemic responses such as fever (hypothalamus) and
the acute phase response (liver) (Smale, 2010). If not properly contained, the prolonged
expression of these toxic molecules has harmful and destructive effects associated with
chronic inflammation. The stimulus selective and inducible expression of the IE genes is
often restricted to a specific cell type, and their expression does not require de novo
protein synthesis (Herschman, 1991). Efficient activation of the IE responders requires a
collaborative endeavor of transcription factors, coactivators, and chromatin modifiers,
targeted to the regulatory sequences residing within gene promoters and enhancers.
Various combinations of these factors are recruited to the regulatory regions of IE genes
to establish favorable chromatin architecture and mediate recruitment of the transcription
machinery. Often being separated by thousands of base pairs, the transcription factors
mediate physical associations between distant promoters and enhancers to serve as an
additional regulatory step controlling gene expression. In resting cells, IE genes are
maintained in a repressed/poised state ready for a rapid induction in response to stimulus.
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Eukaryotes package their DNA into a higher order structure known as the
chromatin fiber. The basic units of chromatin are nucleosomes, which are comprised of 2
copies of 4 core histone proteins H2A, H2B, H3, and H4. The central H3/H4 tetramer is
surrounded by the H2A/H2B dimers (Henikoff, 2008). The 147 bp of DNA wrapped 1.65
turns around each of these octameric structures represent the fundamental unit of the
chromatin fiber (Radman-Livaja and Rando, 2010). An average distance between the
midpoints of two nuclesosmes compacting the human genome is approximately 185 bp.
Nucleosome positioning throughout the genome plays a major role in controlling the
accessibility of DNA regulatory regions and influencing gene expression. Nucleosome
positioning often corresponds to the transcriptional activity of a particular gene. For
instance, the promoters of active genes are usually associated with a nucleosome free
region (NFR), which facilitates the formation of pre-initiation complex formation (PIC)
and RNA Polymerase II (Pol II) entry. The first, and usually most prominent, phased
nucleosome (non-randomly positioned nucleosome along DNA) downstream of the TSS
is referred to as +1. Contrary to yeast, in humans the nucleosome positioned within the
NFR is defined as -1 and the first most prominent nucleosome upstream of the TSS is
designated as -2. An additional aspect of gene packaging lies within the nature of
covalent modifications associated with the N-terminal nucleosome histone tails that are
subjected to the binding of various histone modifiers and transcriptional activators and
repressors (Jiang and Pugh, 2009). Figure 2 illustrates the nucleosome positions, Pol II
occupancy, and the spatial distribution of several chromatin marks used in literature and
this study as common indicators of transcriptional competency.
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Figure 2. Illustration of the paused Pol II dynamics and chromatin landscape along a typical gene.
Shown here are the various transcriptional permissive (+) and repressive (-) chromatin marks as well as
their reported distribution throughout a typical gene locus (Henikoff and Shilatifard, 2011; Owen-Hughes
and Gkikopoulos, 2012). Transcriptionally permissive modifications include H3K9ac, H3K4me3,
H3K36me3, H3K4me1, and H3K27ac. H3K9ac is present at the promoter, H3K4me3 is most abundant in
the vicinity of the +1 nucleosome, H3K36me3 increases towards the 3’ end of the structural gene, and
H3K27ac is distributed upstream and throughout the gene locus (Henikoff and Shilatifard, 2011; OwenHughes and Gkikopoulos, 2012). H3K4me1 marks enhancers of LPS inducible genes within the setting of a
macrophage genome (Ghisletti et al., 2010; Heinz et al., 2010). Transcriptionally inactive genes are
enriched for modifications such as H3K9me1 and H3K27me3. Typically phased nucleosomes are labeled
according to their position relative to the transcription start site (TSS). Illustrated is also the Pol II
progression throughout the locus. The paused Pol II complex is represented as a peak, located 50bp beyond
TSS. Paused Pol II is associated with the C-terminal domain phosphorylation at serine 5 and the presence
of negative elongation factor (NELF). The interplay between NELF and positive elongation factor b (PTEFb) regulates the Pol II transition into the elongation state.
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Recent reports from Drosophila and human genome studies revealed a new
regulatory step within the transcriptional cycle of Pol II. These observations changed the
way we think about transcriptional control of primary response genes. Pol II is pre-loaded
at the 5’ regions of many genes that are inactive or minimally expressed (Gilchrist et al.,
2008; Guenther et al., 2007; Kininis et al., 2009; Muse et al., 2007; Rahl et al., 2010;
Zeitlinger et al., 2007). In addition, TBP appears to be constitutively present on these
genes (Donner, 2010). As shown by in vitro studies, these complexes are poised for rapid
transcription, and will resume elongation upon the addition of nucleotides (Fish and
Kane, 2002; Greive and von Hippel, 2005). Activation of the paused genes by an
exposure of cells to developmental and environmental stimuli is dependent on the release
of Pol II from its paused state (Wu and Snyder, 2008). The interplay of several elongation
factors and chromatin modifiers is responsible for maintaining and liberating the paused
Pol II. One of the proteins that induces Pol II stalling is the negative elongation factor
(NELF), composed of four subunits, NELF-A, NELF-B, NELF-C/D, and NELF-E, which
was proposed to interact with the nascent RNA emerging from Pol II, using its RNA
recognition motif (RRM) (Gilchrist et al., 2008; Wu et al., 2003; Yamaguchi et al., 2002).
Positive transcription-elongation factor-b (P-TEFb) has been shown to rescue the paused
Pol II by simultaneously phosphorylating NELF as well as the Pol II C-terminal domain
at serine 2 (S2P CTD), causing its transition into the state of elongation (Bres et al., 2008;
Ni et al., 2008; Price, 2000). The differential modifications of Pol II CTD, as well as its
interactions with the components of the splicing machinery, play a crucial role during the
regulation of transcriptional dynamics. The mammalian CTD is a part of the largest Pol II
subunit (RPB1) and contains 52 tandem repeats of a heptapeptide with the consensus
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sequence Tyr-Ser-Pro-Thr-Ser-Pro-Ser (Buratowski, 2009). It has been postulated that
the differential phosphorylation states of the CTD correspond to either a paused or an
actively elongating Pol II. The phospho-serine 5 modified CTD (S5P CTD) is located
primarily at the upstream regions of the genes as part of the engaged but stalled Pol II
complex. Cyclin-dependent kinase 7 (CDK7), a subunit of the general transcription factor
TFIIH, has been shown to mediate this S5P phosphorylation event, since the newly
recruited Pol II is in a hypo-phosphorylated state (Brookes and Pombo, 2009). This
modification aids in the process of the methylguanosine cap addition to the 5’ end of the
nascent mRNAs. ChIP experiments have shown that serine 2 phosphorylation by P-TEFb
(which contains a CDK9 subunit) increases towards the 3’ end of the actively transcribed
genes. The serine 7 phosphorylation (S7P) serves as an additional site for Pol II CTD
phosphorylation at a subset of genes encoding small nuclear (sn) RNAs in mammalian
genomes (Egloff, 2012). This S7P modification is recognized by the RNA Pol IIassociated protein 2 (RPAP2), which recruits the Integrator complex responsible for the
RNA 3’ end processing (Egloff et al., 2012).

The spatial alteration of the CTD

phosphorylation pattern corresponds to the recruitment of various factors responsible for
proper pre-mRNA co-transcriptional processing including splicing and addition of the
poly-A tail (Buratowski, 2003; Egloff and Murphy, 2008). In addition, the sequentially
phospho-modified CTD serves as a landing pad for the recruitment of chromatin
remodeling and modifying factors including the histone methyltransferases Set1 and
Set2, as well as the histone acetyltransferases CBP/p300 and PCAF (Brookes and Pombo,
2009; Munoz et al., 2010; Weake and Workman, 2010). In fact, a specific set of
chromatin marks, which are differentially distributed throughout the gene coding and
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regulatory regions, have also been associated with Pol II transcription dynamics. For
instance, tri-methylation of lysine 4 at histone 3 (H3K4me3) and the acetylation of lysine
9 at histone 3 (H3K9ac) are present at the promoter proximal regions of either actively
transcribed or paused genes. In contrast, the tri-methylated lysine 36 of histone 3
(H3K36me3) downstream of the gene promoters is associated with actively elongating
Pol II complexes (Brookes and Pombo, 2009; Wu and Snyder, 2008).
The phenomenon of Pol II pausing is thought to contribute to gene regulation in a
variety of ways. Some reports indicate that the paused Pol II complexes provide a means
for a rapid transcriptional response, as well as the coordinate induction of multiple genes
(Fuda et al., 2009). Evidence suggests that Pol II pausing ensures the proper assembly of
capping factors at the 5’ end of genes, as well as the accurate formation of a Pol II
elongation complex. Additional reports indicate that Pol II also pauses at the 3’ end of
genes, where it associates with protein machineries that direct the final steps of mRNA
processing, including cleavage and polyadenylation (Glover-Cutter et al., 2008). Lastly,
studies in Drosophila showed that the stalled Pol II serves as a physical barrier by
preventing promoter-proximal nucleosome assembly (Gilchrist et al., 2008). This
mechanism contributes to the accessibility of the core promoter for subsequent
recruitment of Pol II and proper gene activation (Gilchrist et al., 2008). Pol II pausing is
also associated with the negative regulation of gene expression. As recently reported, the
NELF-induced paused Pol II complex at the JunB promoter is present prior to induction
and persists during the transcription of the gene. According to the report, the gene is not
activated to the full extent, because of the attenuating effects of paused Pol II (Aida et al.,
2006). Additional studies investigating Pol II pausing will be required in order to better
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resolve the role played by this regulatory step that influences the transcription of
eukaryotic genes.

A signal (LPS) inducible enhancer and a cell type specific promoter constitute the
main regulatory regions of the human IL1B gene.
Interleukin-1 (IL-1) is a potent mediator of inflammatory responses with
diverse biological activities affecting the endocrine, nervous, and immune systems. IL-1
has been shown to cause fever, activate acute-phase responses, modulate lymphocyte
function, as well as induce both destructive and reparative changes in mesenchymal
tissues (cartilage, bode, muscle) (Dinarello, 1986; Dinarello, 1994). The gene encoding
IL-1 is located on human chromosome 2 within the homologous IL-1 family gene
cluster, which contains 8 additional IL-1-like genes whose products have also been
associated with diverse pro- and anti-inflammatory activities. The primary sources of this
molecule in humans and mouse are activated monocytes/macrophages as well as related
cells of the myeloid lineage. The transcriptional profile of IL1B in stimulated monocytes
is reflected by rapid induction followed by a decreased sustained expression that lasts for
several hours (Fenton et al., 1987). The past work in our and other groups has revealed
numerous regulatory sequences upstream of the IL1B coding region that bind an array of
transcription factors, including Spi1/PU.1 (Spi1), C/EBP, NF-B p65, IRF4/8, and
CREB, some of which are restricted to the monocytic-cell lineage, such as Spi1, and
IRF4/8. Transcription factor interactions and binding to different positions along the IL1B
regulatory regions likely account for the stringent regulation of this IE gene. In the past,
the study of IL1B regulatory regions focused primarily on defining the specific DNA
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sequences and their capabilities for binding various transcriptional activators. The past
collection of studies resulted in the comprehensive dissection of the complex regulatory
elements within the IL1B locus. Figure 3 depicts the schematic representation of IL1B
regulatory regions as well as the associated binding of transcription factors controlling
IL1B transcription. Transient transfection studies using selected fragments of the IL1B
trans-gene into murine RAW 264.7 (RAW) monocytes, revealed important regulatory
sequences 3kb upstream of the TSS between -3134 and -2729 (Shirakawa et al., 1993).
This stimulus-specific enhancer, termed the upstream induction sequence (UIS), is
divided into 9 distinct regions (A through I) some of which contain collections of binding
sites for an array of constitutively bound, as well as inducible, transcription factors. The
C/EBP, a critical myeloid gene regulator (Pham et al., 2007), binds to the enhancer E
and I regions following LPS stimulation. Mutation of these binding sites reduces the
activity of IL1B promoter driven CAT plasmids transfected into monocyte cell lines,
suggesting its functional role in the gene activation (Shirakawa et al., 1993; Tsukada et
al., 1994b).
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Figure 3. Depiction of the IL1B gene regulatory region.
Shown are the various regulatory regions that are known to affect IL1B induction. Magnified on the bottom
left are the enhancer regions and top right the promoter transcription factor binding sites. LPS induced
binding of the effector proteins is highlighted with red boxes and arrows. Illustrated is also the enhancer
specific protein complex binding to the LILRE, as well as the looping mediated by the association of
constitutive Spi1 (promoter) and LPS induced C/EBP (enhancer). Figure was provided by the courtesy of
P.E. Auron.

In addition, these studies revealed an important role of the interferon stimulation
response element (NF-1) binding site within the enhancer F region during IL1B
regulation. Chromatin immuno-precipitation (ChIP) studies showed cooperative
association of non-tyrosine phosphorylated (NTP)-Stat1, IRF-8 and Spi1 bound to an
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LPS/IL-1 Responsive Element (LILRE), located between the positions -2880 and -2849
in unstimulated monocytes. Upon LPS treatment, the trans-activation domain of IRF8
likely becomes phosphorylated at the tyrosine residue 727, possibly acting as a switch
necessary for the rapid activation (up to 80%) of IL1B transcription (Unlu et al., 2007).
Continuing with this mechanism, a recent study argued that LPS activates a casein
kinase-2 (CK2)-dependent phosphorylation of the pre-associated Spi1 within the
complex. This phosphorylation event of Spi1 at the serine 148 triggers the replacement of
IRF-8 by its relative IRF4, which acts to enhance the recruitment of Pol II complex to the
IL1B promoter (Zhang et al., 2008). Another site within the UIS that is necessary for
proper IL1B gene activation is located within the enhancer I-region (-2768 to -2760),
which contains the composite sequences recruiting competing heterodimeric complexes
consisting of C/EBPβ and CREB and a CREB-like factor, possibly ATF4 (Figure 3)
(Auron and Webb, 1994; Chandra et al., 1995; Tsukada et al., 1994). All of these
activators and their modifications are needed for proper IL1B induction, in order to
overcome the unknown nature of the potent suppressive effect of region H in the
enhancer, which acts as a silencer for LPS induction (Tsukada et al., 1994b). Another
feature likely enabling the observed rapid induction of IL1B is associated with the
accessible/nucleosome-free promoter architecture, containing constitutively bound
transcription factors and activators (Liang et al., 2006). One such protein, central to IL1B
expression, is the previously mentioned Spi1, an ETS domain helix-turn-helix (HTH)
DNA binding factor exclusively expressed in the monocytes/myelocytes, B cells, mast
cells, and erythropoietic stem cells (Nishiyama et al., 2004; Pahl et al., 1993). It has been
postulated that this lineage-determining factor facilitates the formation of a NFR,
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exposing binding sites for the LPS-responsive transcription factors in activated
monocytes (Natoli, 2012). Spi1 is a major factor involved in the genome-wide
maintenance of the macrophage lineage (Lawrence and Natoli, 2011). In particular,
recent genome-wide studies revealed a constitutive association of Spi1, often with other
signal inducible factors such as NF-B and C/EBPβ, at the LPS responsive enhancers in
murine macrophages (Ghisletti et al., 2010; Heinz et al., 2010). It is speculated that the
cell-type-restricted expression of IL1B is dependent on Spi1, which constitutively binds
to the promoter at two distinct sites located between -50 to -39 and -115 to -97, relative to
the TSS (Figure 3) (Kominato et al., 1995). In addition to its role as a pioneer factor,
which is capable of binding nucleosome-wrapped DNA and facilitating chromatin
accessibility (Marecki et al., 2004), Spi1 also recruits various activators such as the
HMGB1 (Mouri et al., 2008), JunB (Grondin et al., 2007) and the general transcription
factor TBP, involved in the pre-initiation complex (PIC) formation, responsible for Pol II
recruitment to the promoter (Hagemeier et al., 1993). Our group proposed that C/EBP
bound to the enhancer physically interacts with Spi1 located at the IL1B core promoter
and cooperatively initiates IL1B gene induction. This protein-protein tethering would
bring the IL1B enhancer and promoter into a close proximity resulting in a loop formation
that enhances gene activation (Listman et al., 2005; Yang et al., 2000). In addition to the
enhancer-binding sites, the IL1B promoter also contains two C/EBP binding sites
positioned at -91 and -41 bp upstream of the TSS (Listman et al., 2005). Studies in mouse
monocytes indicate that promoter bound (position -41) C/EBP undergoes p38 MAPKdependent phosphorylation that is required for IL1B induction (Baldassare et al., 1999).
Finally, IL1B transcription requires the recruitment of NF-B p50-p65 hetero-dimer to a
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putative binding site located 297 bp upstream of the TSS (Figure 3). Point mutations
within this sequence significantly reduced IL1B activity (Hiscott et al., 1993). The proper
activation of this inducible gene requires a series of combinatorial associations (often in
protein complexes) and posttranslational modifications of these factors in a timedependent fashion that are ultimately responsible for the recruitment of Pol II to the IL1B
promoter.

IL-1 gene family members in human monocytes.
The human IL-1 family consists of 11 genes whose identity have been only
recently identified and their biological relevance during the inflammatory responses is
presently being investigated. The members include IL-1 (IL-1F1), IL-1 (IL-1F2), IL-1
receptor antagonist IL-1Ra (IL-1F3), IL-18 (IL-1F4), IL-36ra (IL-1F5), IL-36 (IL-1F6),
IL-37 (IL-1F7), IL-36 (IL-1F8), IL-36 (IL-1F9), IL-38 (IL-1F10), and the most
recently added member IL-33 (IL-1F11). As Figure 4 illustrates, all of the members are
mapped to a cluster on the long arm of chromosome 2, except IL-18 and IL-33 (not
included in the Figure), which reside on chromosomes 11 and 9, respectively (Liew et al.,
2010). Emerging evidence suggests that IL-1, IL-1, IL-18, IL-36, IL-36, IL-36,
and IL-33 have pro-inflammatory, while IL-1Ra, IL-36ra, and IL-37 have antiinflammatory, functions. The role of IL-1F10 during the mediation of immune responses
is not well understood (Dinarello; Dunn et al., 2001).
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Figure 4. IL-1 family gene cluster on the long arm of chromosome 2.
Shown is a magnified section of the chromosome 2, which contains a gene cluster of 9 IL-1 family
members. The arrows within the genes annotate their transcriptional direction. Certain genes show more
then one predicted coding sequences of varying lengths. This figure was generated using the UCSC
genome browser website.
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Endotoxin Tolerance
Endotoxin tolerance, also known as desensitization, is defined as a decreased
responsiveness of the host’s (cells and organisms) to either repeated or prolonged LPS
stimuli, after an initiation of the primary immune response (Fan and Cook, 2004). This
state of immune-paralysis has been associated with a protective function, in preventing
the excessive and uncontrolled onset of potentially harmful inflammatory responses to
the host organism (Arbibe and Sansonetti, 2007). The first evidence suggesting endotoxin
tolerance came from the 1947 reports by Beeson. His studies revealed decreased fever
responses in rabbits repeatedly treated with bacterial pyrogens (Beeson, 1947a, b).
Although some aspects of the endotoxin tolerance phenomenon have been elucidated, the
mechanisms at the level of transcriptional regulation are still largely unknown. In the
search for new answers, various laboratories often used a variable experimental set up in
cell culturing and LPS treatment that resulted in some inconsistent results throughout the
literature. A recent study using murine bone marrow-derived macrophages categorized
the LPS responsive genes into two classes, tolerant and non-tolerant. The report argues
that the protein products of the tolerant genes are associated with potent proinflammatory functions and therefore their expression is rapid and transient. They are
refractory to an additional stimulus in order to prevent their harmful effects and potential
tissue damage. On the other hand, the genes in the non-tolerant category encode various
anti-microbial products whose expression remains inducible even after the repeated
stimuli. These molecules are not associated with the harmful effects to the host. Instead,
their re-activation is beneficial to the host by providing long-term protection form
invading pathogens. The hypo-responsiveness of the tolerant genes was attributed to the
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loss of histone modifications associated with gene activation (Foster et al., 2007). Both,
TNF and IL1B were included in the list of genes that were unable to respond to the
secondary LPS challenge. The issue of chromatin dynamics during endotoxin tolerance
was explored by Gazzar et. al, indicating that increased repressive methylation at
H3K9me1, induced binding of heterochromatin-binding protein 1 (HP1) to TNF
causing its transcriptional repression (El Gazzar et al., 2007). Additionally, a series of
studies showed that the tolerant phenotype results form an increase in the nuclear
concentration of NF-B p50–p50 homodimer, which lacks a proper TAD, causing
transcriptional deregulation of specific genes including TNF and IL1B (Kastenbauer and
Ziegler-Heitbrock, 1999; Ziegler-Heitbrock et al., 1994). Two reports using human cell
lines (LaRue and McCall, 1994) and a mouse model (Zuckerman et al., 1991) revealed
two contradictory tolerant and non-tolerant properties, respectively, for the il1b gene,
adding more dilemma to the endotoxin tolerance subject. Previous studies in our
laboratory also showed a partial incomplete IL1B tolerance of LPS (Fenton et al., 1987)
and a novel complete tolerant property for IL1B by using phorbol ester (PMA) as the
secondary challenge (Fenton et al., 1987). Lastly, a recent study using non-monocytic
cells showed that endotoxin tolerance manifests itself in a cell type specific manner
(Wang et al., 2011). Collectively these reports suggest that the many aspects of endotoxin
tolerance associated with transcriptional repression are still not well understood.
Although the tolerant nature of TNF has been consistently reported, studies of IL1B
tolerance are not yet conclusive. Since the effects of endotoxin tolerance are evident in
various diseased states, including sepsis, non-infections systemic inflammatory
responses, trauma, and hemorrhagic shock, the understating of the underlying
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mechanisms associated with this phenomenon is significant for their treatment (Cavaillon
et al., 2003).

The Role of HIF-1 in innate immunity and cancer
Hypoxia induced factor (HIF-1) plays a major role as a regulator of oxygen homeostasis
in cells. During the state of normal oxygen levels (normoxia), HIF-1, a helix-loop-helix
DNA binding factor, rapidly undergoes post-translational modification by the action of
the enzyme prolyl hydroxylase (PHD), which causes the ubiquitin-mediated degradation
of HIF-1. The PHD activity is inhibited under conditions of oxygen deprivation
(hypoxia), which induces HIF-1 stabilization and subsequent translocation to the
nucleus, where it binds a DNA recognition motif known as the hypoxia-response element
(HRE) and associates with co-activators such as p300/CBP, which activate target genes
(Semenza, 2003) (Figure 5). Since hypoxia is a well-known feature of inflamed and
cancerous tissues, the understanding of the homeostatic imbalance of HIF-1 activity has
significant clinical implications.
Otto Warbug reported the first connection between malignant cells and metabolic
activity in 1927 (Warburg et al., 1927). Today, it is well established that tumor cells
undergo a metabolic shift resulting in the upregulation of the anaerobic glycolysis as a
major source for their energy production. The alteration of mitochondrial physiology is
due to mutations in the genes encoding succinate dehydrogenase (SDH) and fumarate
hydratase (FH) enzymes associated with the TCA (Krebs) cycle, which links glucose
utilization with oxidative phosphorylation (Gottlieb and Tomlinson, 2005). Often
associated with the state of pseudo-hypoxia, the buildup of succinate and fumarate acts as
24

a direct inhibitor of PHD, causing activation of HIF-1. HIF-1, in turn, causes the upregulation of genes involved in the anaerobic glycolysis, promoting neurovascularization
and deregulation of cell apoptosis (Gottlieb and Tomlinson, 2005), contributing to the
tumorigenesis. The metabolic changes associated with the upregulation of anaerobic
glycolysis are also apparent in mononuclear cells residing within tumors and inflamed
tissues (Tannahill and O'Neill, 2011). Several physiological processes controlling
macrophage activity within inflamed and ischemic tissues are closely associated with
HIF-1 mediated alterations in the transcription of a wide array of target genes.

Figure 5. Glucose metabolism and regulation of HIF-1.
Shown is a glycolysis pathway and the effects of various substrates (mediating a pseudo-hypoxia) whose
build-up causes inhibition of prolyl hydroxylase (PHD) and the up-regulation of HIF-1. Inhibitory
pathways are marked with red colors. The effects associated with a drop in oxygen levels (hypoxia) are also
depicted in the Figure.
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The hypoxic microenvironment of inflamed tissues has been shown to trigger
HIF-1 and alter the expression of proteins associated with macrophage survival,
expression of cytokines/chemokines, and tissue angiogenesis (Murdoch et al., 2005). In
addition to relieving the inhibitory effects of PHD, the TLR4 mediated activation of NFB was shown to augment the transcription of Hif1 and further amplify its regulatory
potential (Nizet and Johnson, 2009).
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HYPOTHESIS AND SPECIFIC AIMS
IL1B and TNF are immediate early genes induced in response to TLR4 activation
of monocytes. Upon monocyte stimulation, TNF undergoes rapid induction and complete
transcriptional shut down within a few hours. IL1B is expressed with similar initial
kinetics, but in contrast to TNF its expression is not completely inhibited and remains
sustained for many hours post-stimulation. In addition, TNF is refractory to subsequent
LPS stimulation. In contrast, IL1B is less sensitive to endotoxin tolerance and can be reactivated when exposed to a secondary LPS challenge. One primary transcription factor
NF-B has been reported to regulate the expression of these IE genes (Collart et al.,
1990; Hiscott et al., 1993). Since the expression profiles of IL1B and TNF are quite
distinct, I hypothesize that additional regulatory mechanisms control the expression of
IL1B. A series of kinetic ChIP experiments analyzing various transcription factors and
nucleosome positioning and modification was performed in order to clarify the
mechanisms responsible for the decreased, but sustained, transcriptional activity of IL1B,
as well as its ability to escape endotoxin tolerance. In order to precisely define the
importance of selected transcription factors, I performed transient transfection
experiments using HEK 293 cells, as a “surrogate-monocyte” cell system. By adding
combinations of signaling activators and transcription factors, an LPS stimulated
monocyte environment can be mimicked within these cells with concomitant induction of
developmentally quiescent IL1B. On the basis of in vitro studies, functional cooperation
between enhancer bound C/EBP and promoter bound Spi1 via DNA looping has
previously been proposed by our laboratory as a mechanism for IL1B induction (Listman
et al., 2005; Yang et al., 2000). To validate the possible LPS induced chromatin looping
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as a regulatory step for IL1B gene induction, chromatin conformation capture analysis
was performed. Lastly, I investigated the expression of IL-1 family members at the
primary IL1 locus on chromosome 2 and two of its distant members on chromosomes 9
and 11 in resting and activated human monocytes. According to my preliminary data, I
hypothesize that this gene family will be coordinately expressed following LPS
stimulation. The synchronous expression of the IL-1 gene family members suggests that
they may be transcribed as a single structural-functional entity known as transcription
factory. Since many transcriptional mechanisms are conserved among higher eukaryotes,
the new information obtained from this research will be applicable to other rapidly
induced genes. Because the regulation of gene expression is central to cell growth,
differentiation, and physiological responses to environmental stress, it is important to
understand the mechanisms underlying these processes. Especially important is the
activation of pro-inflammatory genes such as IL1B, whose over-expressed bioactive
products can be destructive to tissues. Given that extensive release of these
homeostatic/immune-mediators is associated with numerous autoimmune diseases, an
understanding of their transcriptional control can provide a means for developing new
inhibitory therapeutics. Accordingly, the following specific aims were proposed in order
to better understand the transcriptional regulation of IL1B:
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Aim 1. Execution of positional-temporal ChIP studies of IL1B vs. TNF induction and
transcriptional shut down.

Aim 2. Resolving the molecular nature of gene specific desensitization/immunetolerance of IL1B and TNF genes.

Aim 3. Determining the role of Spi1 in induction of the IL1B gene and to characterize
the relative importance of C/EBPβ and p65 during IL1B induction in monocytes and in
HEK 293 cells supplemented by ectopic expression of monocyte-specific factor.

Aim 4. Investigation of the LPS inducible mRNA expression of IL-1 gene family
members in human monocytes.
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MATERIALS AND METHODS
Cell Culture
THP-1 cells were cultured in RPMI media (10-040-CV, Cellgro) supplemented with 10%
heat-inactivated fetal bovine serum (FBS), 1% Penicillin/Streptomycin solution (30-002CI, Cellgro) and 500 µl of 2ME (21985-023, Invitrogen). HEK 293 cells, MG 63 cells,
grown in EMEM (10-010-CV, Cellgro) and HuT 102 cells grown in RPMI, containing
10% heat-inactivated FBS and 1% Penicillin/Streptomycin Solution, were obtained from
American Type Culture Collection. RAW 264.3 were cultured in DMEM (10-013-CV,
Cellgro) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 1%
Penicillin/Streptomycin Solution. Adult human elutriated monocytes were purchased
from Advanced Biotechnologies (07-210-001). Monocytes were cultured in DMEM with
20% FBS (SH3007003N, Fisher), 1% Penicillin/Streptomycin, and 50 µg/ml Gentamicin
(1676045, MP Biomedicals) for 7 days until macrophage monolayer was established. On
day 7 and 8, 90% of the old media was replaced with 10 ml of fresh media to remove all
non-adherent cells. Kinetic LPS stimulations were conducted on day 9 of cell culture.
Bone marrow from C57BL/6 mice (Harlan Laboratories, UK) was differentiated for 10 d
in granulocyte-macrophage colony-stimulating factor (4% (vol/vol) J588 myeloma cell
supernatant) or for 7 d in M-CSF (20% (vol/vol) L929 mouse fibroblast supernatant) in
typical media preparations for the preparation of BMDMs.
Reagents and Treatment Conditions
In all experiments, monocytes were stimulated with 1 µg/ml of E. coli 055:B5
Lipopolysaccharide (LPS) (Sigma) for indicated time periods. In the case of restimulation experiments, cells were initially stimulated with 1µg/ml of LPS and then re-
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stimulated with additional 1µg/ml of LPS without washing the media. All inhibitors used
in the study were applied one hour prior to LPS treatments in following concentrations; 1
µM/ml MG132 (474790, Calbiochem), 10µM/ml U0126 (V1121, Promega), 10 µM/ml
SB 202190 (152121-30-7, Sigma), 50 µM/ml 5,6-Dichlorobenzimidazole 1--Dribofuranoside (DRB) (D1916-10MG, Sigma) 10 µM/ml of IKK Inhibitor III (BMS345541, Calbiochem), and 25 µM LY294002 (440202, Calbiochem).
Chromatin Immuno-precipitation (ChIP)
ChIP was performed using a modification of the Millipore/Upstate protocol
(MCPROTO407). In brief, a total of 1x107 cells were fixed in 1% formaldehyde (F79500, Fisher) for 10 min at room temperature. Cross-linking was inhibited by addition of
glycine to a final concentration 0.125 M. Cell pellets were washed twice with ice cold
PBS and resuspended in SDS Lysis Buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH
8.1)

supplemented

with

1

µg/ml

Aprotinin

(A6279-5MG,

Sigma),

1µM

phenylmethylsulfonyl fluoride (PMSF) (93482, Fluka), and 1 µg/ml Leupeptin (L97835MG). Samples were sonicated (to generate DNA fragments of 250 base pairs (bp)
average length) on ice using a Fisher Scientific Sonic Dismembrator (Model 100), as
follows: 325 strokes at 100% power followed by 75 stokes at 50% power and centrifuged
at 12000 RPM for 10 min. Chromatin from 5x106 cells was diluted 7-fold in ChIP
Dilution Buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl,
pH8.1, 167 mM NaCl), pre-cleared with protein Agarose/Salmon Sperm DNA beads
(Protein G Agarose, 16-201 Millipore, Protein A Agarose 16-157 Millipore; IgM A4540
Sigma-Aldrich) for 30 min at 4°C, and centrifuged at 10,000 RPM for 2 min. Chromatin
supernatants were incubated at 4°C overnight with respective antibodies (Table 1).
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Aliquots for INPUT and non-specific IgG control samples were included with each
experiment. Samples were precipitated using 40 µl of protein agarose beads, depending
upon specific antibody requirements (Table 1) at 4°C for 2 hours, and subsequently
washed with following solutions: once with Low-Salt Buffer (0.1% SDS, 1% Triton X100, 2mM EDTA, 20 mM Tris-HCl, pH 8.1, 150 mM NaCl), once with High-Salt Buffer
(0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 mM Tris-HCl, pH 8.1, 550 mM NaCl),
once with LiCl Wash Buffer (0.25 M LiCl, 1% IGEPAL-CA630, 1% deoxycholic acid,
1mM EDTA, 10 mM Tris, pH 8.1), and twice with TE Buffer (10 mM Tris-HCl, 1 mM
EDTA, pH 8.0). Immunocomplexes were eluted in two stages for 30 min and 15 min at
65°C with 260 µl and 140 µl of ChIP Elution Buffer (1% SDS, 0.1M NaHCO 3),
respectively. To reverse the cross-linking, eluted samples were treated with 16 µl of 5 M
NaCl and subsequently incubated at 65°C for ≥4 hours. DNA was purified using a
GeneJET PCR Purification kit (Fermentas,

#K0702). Primer pairs against various

regions of human and murine genes were designed using the PrimerQuest software
available at the Integrated DNA technologies website (Tables 2-4). The size of the PCR
products range between 80 and 150 bp. Twenty microliter qPCR reactions containing 2x
Maxima SYBR Green/ROX qPCR Master Mix (K0223, Fermentas), 250 nM of primers,
and 3 µl of precipitated DNA were set up in Fast 96-Well Reaction Plates (4346907,
Applied Biosystems). qPCR reactions were carried out in a StepOnePlus Applied
Biosystems Real Time Instrument. Fold enrichment was calculated based on Ct as 2 (Ct),
where Ct = (Ct Input – Ct IP). Final enrichment values were adjusted by subtraction of the
nonspecific IgG antibody binding.
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Table 1. Antibodies used for ChIP and Western Blot Analyses
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Table 2. Human IL1B ChIP primer sequences

34

Table 3. Human TNF ChIP primer sequences
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Table 4. Human JUNB and HIST1H4K ChIP primer sequences
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Table 5. Murine Il1b and Tnf ChIP primer sequences

RNA Expression Analyses
1x106 cells were plated into 6-well plates (353846, FALCON). Following treatments
cells were transferred into 1.5 ml tubes and centrifuged at 3500 RPM for 3 min at room
temperature. The cell pellets were resuspended in 500 µl of TRIzol reagent (15596-026,
Invitrogen). After addition of 170 µl of Chloroform (C606-1, Fisher) samples were
vortexed, incubated at room temperature for 15 min, and centrifuged for 15 min at 13000
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RPM in 4°C chilled centrifuge. Aqueous layer was removed, combined with equal
volume of Isopropanol (BP2632-4, Fisher), 1 µl of Glycogen (9510, Ambion), and
centrifuged for 10 min 13000 RPM at 4°C. Sample pellets were washed with 500 µl of
75% Ethanol (111ACS200, Pharmaco-AAPER) and centrifuged for 10 min in room
temperature at 14000 RPM. Air-dried pellets were resuspended in 30 µl of RNAse free
water and subjected to DNAse treatments using Turbo DNA-free reagents (AM1907,
Ambion) according to the manufacturer instructions in order to eliminate genomic DNA
contamination. RNA was converted to cDNA using GoScript Reverse Transcription
System (A5001, Promega). Relative expression levels were calculated using Ct
method using B2M and 18srRNA as an endogenous controls. In certain experiments
RNA was directly subjected to an RT-PCR utilizing the Access RT-PCR system (A1250,
Promega).
Transfection Constructs
Luciferase reporter XT-Luc IL1B, wild type IRF8 and mutant IRF8Y211F were as
described (Unlu et al., 2007). Expression plasmids for wild-type C/EBP and the
truncated C/EBPSPL, were constructed and characterized as reported (Tsukada et al.,
1994). Expression plasmids expressing wild-type Spi1 and the dnSpi1 deletion mutant
were constructed as described (Galson et al., 1993; Kominato et al., 1995). The MHCBLuc reporter is as described (Mitchell and Sugden, 1995; Yoshida et al., 2004).
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Table 6. mRNA analyses and qPCR primer sequences

Transient Transfections
293 cells were seeded into 24 well plates to 60-70% confluency. Reporter and expression
plasmids were transfected into 293 cells with FUGENE 6 Transfection Reagent
(11814443001, Roche) at 3 μl of reagent per μg of DNA, according to the manufacturer’s
instructions. Individual expression vectors were transfected as follows: 0.05 μg of Spi1
and 0.1 ug of TRAF6, IRF8, C/EBP, and NF-B into 24 well plates containing 500 µl
of media. Total amount of transfected DNA was maintained constant for each experiment
by addition of empty vector. Endogenous IL1B studies were conducted in 6 well culture
plates with the amount of transfected material adjusted 3 fold.
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Luciferase Assays
At 24 hours after transfection, cells were lysed with 60 l of 1X cell lysis buffer in each
well (24 well plate) and shaken for 20 min at RT. 20 l of supernatant from each well
was used for luciferase assay using Luciferase Assay System (Promega E1501) and
analyzed by Veritas Microplate Luminometer and Software.
Chromatin Conformation Capture (3C)
In brief, a total of 1.5x106 cells were fixed in 2% formaldehyde (F79-500, Fisher) for 10
min at room temperature. Cross-linking was inhibited by addition of glycine to a final
concentration 0.125 M. Cell pellets were collected into 15 ml Falcon tubes and washed
twice with ice cold PBS and resuspended in Lysis Buffer (10mM Tris-HCl pH 8.0, 10
mM NaCl, 0.2% NP-40, supplemented with 1 mM PMSF, and protease inhibitor cocktail
(Sigma) in 1:500 dilution) on ice for 90 min. Samples were centrifuged at 1800 rpm for 5
min, resuspended in 900 μl of 1.2xNEB4 (diluted with 0.3% SDS), and transferred into
1.5 ml Eppendorf tubes. Nuclear lysates were incubated for 1 hr at 37°C with moderate
vortexing. 180 μl of Triton X-100 (final concentration of 1.8%) was added and samples
were incubated for additional 1 hr at 37°C. Portion of chromatin (1 ug) was removed and
treated overnight with MfeI (40 Unit) at 37°C. Lysates were treated with 1.6% SDS and
incubated 60°C for 20 min. 47.5 μl of Lysates were used for ligation reaction (40 μl 10%
Triton X-100, 40 μl ligase buffer (10x), 270 μl H2O, 2.5 μl T4 DNA ligase) that was
carried out for 16 hours at 16°C. Next, 100 µg/ml of proteinase K was added to samples
that were subsequently incubated overnight at 65°C. Next day, samples were treated with
RNase A (0.5 µg/ml) for 30 min at 37°C and DNA was extracted. PCR products were
amplified using following primers 1’: 5’-GGG GCC TCC AAA TCA CTA AGC-3’, 2:
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5’-GCA TTG CCC CAT GGC TCC AAA AT-3’, 3’: 5’-TCT CTA CCT TGG GTG CTG
TTC TC-3’, 4: 5’-CCG CTG TAA CGG GCA AAA GTT TC-3’. GoTaq PCR Core
System I (M7660, Promega) was used for PCR analyses.
Site Directed Mutagenesis
XT-Luc binding site mutation reporter constructs: C/EBP I region binding site (XT-I
c/g-Luc), NF-ΚB site at position -300 (XT-300B-Luc), and the double I(c/g)/-300B
were generated using QuickChange XL Site-Directed Mutagenesis Kit (Stratagene
200516) using appropriately mutated primer sequences. Primer pairs listed in were used
for site directed mutagenesis. The XT-I(c/g)-Luc plasmid was used as a template for
generation of the double mutant (I region/-300 NF-B site) construct. XT-300mut (F)/(R)
were used as primers.
Table 7. Site-directed mutagenesis primer pairs
IL1B enhancer I region XT-I (c/g)-Luc primer pairs:
I (c/g) F
I (c/g) R

5’CTGTGGAGACTGTTAGGTCAGGGGGCATTGC3’
5’GCAATGCCCCCTGACCTAACAGTCTCCACAG3’

NF-B site (-300) mutation
XT-300 F

5’AACATTCTTCTAACGTGTGAAAATACAGTATTTTAATGTGGACATC3’

XT-300
R

5’GATGTCCACATTAAAATACTGTATTTTCACACGTTAGAAGAATGTT3’
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RESULTS
IL1B and TNF mRNA are Differentially Expressed in Monocytes
Steady-state mRNA kinetic profiles of the IE genes IL1B and TNF in a human cell
line (THP-1) and human primary macrophages (hPBMCs), as well as a murine cell line
(RAW 264.7), revealed differences in the transcriptional responses of these two genes.
The expression profiles were assessed by various methods including agarose gel
resolution of reverse transcribed (RT) PCR products (Figure 6) and Real Time
Quantitative PCR (RT-qPCR) (Figure 7). TNF undergoes rapid induction and significant
transcriptional shut down within a few hours of LPS treatment. In contrast, IL1B is also
rapidly induced and then decreased, but is not completely switched off, continuing
expression for many hours post-stimulation.

Figure 6. IL1B and TNF expression in LPS stimulated THP-1 cells.
THP-1 cells were stimulated with 1g/ml of LPS for indicated time points and 3% agarose gels were used
to resolve the band pattern of amplified products. Following a strong transient phase, the expression of
IL1B decreases but is sustained for hours post stimulation. In contrast to IL1B, expression of TNF
terminates 3 hours post stimulation after its initial transcriptional response. Increased dosage of LPS (5
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g/ml and 10 g/ml) causes amplified and lengthened initial expression of the IL1B and TNF genes. The
amplification of beta actin serves as a loading control.

Figure 7. Comparison of IL1B and TNF Transcription in Monocytes.
Steady-state mRNA kinetics for IL1B and TNF transcripts in LPS stimulated THP-1, RAW264.7, and
hPBMCs. Transcript levels were normalized to beta 2-microtubulin (B2M), and then as the ratio of amount
in resting vs. LPS-treated cells. Circles denote mRNA levels for primary LPS challenge. Squares show
transcript levels following re-stimulation as indicated by arrows. Data used for generation of this figure are
presented in Appendix A.

Transient expression patterns for these two genes are reflective of their
transcription status because of the short mRNA half-life mediated by AU-rich element
(ARE) degradation (Chen et al., 1994; Fenton et al., 1988). ARE, localized within the 3’
untranslated region of many pro-inflammatory genes influence their rapid degradation
and/or repress their translation. Inhibitory properties of these elements are conveyed by
the recruitment of ARE-binding proteins, which utilize various mechanisms for targeting
and eliminating accumulating messages (Wu and Brewer, 2012). The stability of mRNA
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is an important feature shaping the classical transient temporal pattern of the IE proinflammatory gene expression. As Figure 6 reveals, an increased amount of LPS
stimulus (from 5 to 10 g/ml) caused a more robust and prolonged transient expression
pattern of both genes.
Additional differences between these two genes were also apparent in resting
human monocytes, in which basal levels of predominantly full-length unspliced TNF, but
not IL1B, transcripts were detected (Figure 8A). Kinetic mRNA profiles within the first 3
hours revealed that TNF transcript production is 30 minutes faster than that of IL1B
(Figure 8B).

A

B

Figure 8. Analysis of IL1B and TNF mRNA splicing efficiency and expression kinetics in resting and
stimulated THP-1 monocytes.
The IL1B and TNF gene expression data was normalized to the endogenous 18s ribosomal RNA (18s
rRNA) gene expression. (A) qPCR data comparing the splicing efficiency of IL1B and TNF mRNA in
resting THP-1 cells. cDNA samples were prepared using random primer directed reverse transcription.
Selective amplicons were designed for the detection of un-spliced/primary (primers targeting sequence
within a single intron) and spliced (spanning the last intron and splice site) transcripts. (B) qPCR analysis
of LPS-treated human THP-1 monocytes (High resolution 0-3 h kinetics).

44

Semi-quantitative analysis revealed that approximately 20% of these rapidly
accumulated TNF messages appear to be incompletely processed primary transcripts
(Figure 9A, B, C).

A

B

C
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Figure 9. Un-spliced TNF transcripts in LPS treated THP-1 cells and hPBMC.
(A) IL1B and TNF mRNA splicing efficiency in LPS stimulated THP-1 cells and hPBMCs, as measured by
comparing the total (amplicons designed within a single exon containing both spliced, and un-spliced
products) vs. un-spliced/primary (within single intron) transcripts. The qPCR data are normalized to the
endogenous 18srRNA levels. Shown are 3% agarose gels resolving the presence of spliced and/or unspliced mRNAs of IL1B (top gel) and TNF (bottom gel) genes expressed in LPS treated THP-1 cells (B)
and human primary macrophages (C). Black labels indicate the 500 bp reference marks and the sizes of
properly spliced mRNAs (149 for IL1B, and 114 for TNF). The red numbers denote the expected size of the
intron-retaining unspliced transcripts (867bp for IL1B and 415bp for TNF). Retention of the intron
sequence within the TNF gene causes a 301 bp shift and creates an additional lower intensity band at the
415 bp mark.
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RNA polymerase II (Pol II) ChIP-qPCR was employed in order to directly
measure the transcriptional status of IL1B and TNF in monocytes. Series of primer pairs
scanning throughout the promoter proximal regions and structural parts of the genes were
designed to accurately characterize the binding enrichment of Pol II and various factors at
the IL1B and TNF loci (Figure 10A).

A

B
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Figure 10. Schematic representation of ChIP-qPCR amplicons and generation of the data profiles for
resting (0h), 1h, and 5h LPS treated THP-1 cells.
(A) Schematic of IL1B and TNF gene structures showing exons (solid boxes), positions of ChIP amplicons
(midpoint relative to TSS), and important transcription factor binding sites (C: C/EBP, : NF-κB, and S:
Spi1) within regulatory regions (open boxes). (B) Illustration of a sample Pol II ChIP used for generation of
a representative diagram. Each colored line tracing the ChIP enrichment bars, represents a specific LPS
treatment time point 0h (black), 1h (red), and 5h (green). This color-coding is used in all figures that
contain similar kinetic ChIP data. The enrichment values were normalized to the input DNA in all ChIP
experiments. ChIP data presented are representative of at least 2 independent experiments.
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The bar graphs obtained from ChIP-qPCR experiments were used to generate the
diagrams that represent the average enrichment data sets. Figure 10B illustrates a tracing
pattern for a sample Pol II experiment. Pol II occupancy kinetics, particularly in the THP1 cells (Figure 11), mimic the respective steady-state mRNA profiles confirming that the
sustained expression of IL1B shown in Figure 11 is a result of a continuous polymerase
engagement and not necessarily an increase in mRNA stabilization.

Figure 11. Pol II occupancy at the il1b and tnf loci.
Pol II ChIP throughout the il1b and tnf loci in resting (black), 1h (red), and 5h (green) LPS stimulated THP1, RAW264.7, and hPBMC cells. Vertical gray bars locate the positions of important gene landmarks.
These include TATA box and the canonical Pol II pause position (approximately 30 bp upstream and 50 bp
downsteam of TSS, respectively). Data used for generation of this figure are presented in Appendix B.

Further kinetic analysis of the transient phase of THP-1 cell gene activation
revealed a 15 minute delay in Pol II recruitment to IL1B (Figure 12), consistent with the
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observed 30 min delay seen in mRNA profiles (Figure 8B). Increased Pol II binding at
the TNF promoter was detected as early as 15 min post-stimulation (Figure 12). Of note,
the transient nature of Pol II enrichment in RAW264.7 cells and human primary
macrophages is less apparent due to the prolonged early phase of IL1B and TNF
transcription in these cells (Figure 7).

Figure12. Kinetic ChIP analysis of Pol II recruitment to the IL1B and TNF gene promoters.
Pol II recruitment was measured at the promoter region and a downstream site for IL1B and TNF in resting
or LPS stimulated monocytes. The indicated time points underneath the graph correspond to the LPS
treatment kinetics used for the ChIP assay.

I next asked, whether the observed differential shutdown of these two immune
genes contributes to their ability to be resistant to reinduction (tolerized), when exposed
to a secondary LPS stimulus. A previous report argued that murine Ilib and Tnf are
refractory to reactivation due to a plethora of intrinsic immuno-protective mechanisms
commonly recognized as endotoxin tolerance (Foster et al., 2007). Endotoxin tolerance
results in a decreased responsiveness of certain rapidly-induced monocyte genes to
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repeated LPS stimulation. In my reactivation experiments, cell cultures were stimulated
with LPS for indicated times with an equal dose of secondary LPS (Figure 7, arrows and
boxes) administered for 2.5 hours to unwashed cultures, prior to assay (Figure 7, dotted
lines). In agreement with the earlier report, my data indicate that tnf genes are tolerized,
so that once activated they cannot be re-expressed by additional LPS treatment. In
contrast to that report, transcription of il1b remained significantly inducible after repeated
LPS exposure, as shown in murine and human cell lines and human primary macrophages
(Figure 7). Additional experiments revealed that increased LPS concentrations used for
secondary stimulation (4.5 g/ml and 9.5 g/ml) did not affect the tolerant nature of TNF.
Figure 13 illustrates and further validates that TNF is rapidly shut down at 3 hours post
stimulation and does not reactivate with subsequent LPS stimulus.

Figure 13. TNF expression is desensitized in THP-1 cells.
Cell cultures were initially stimulated with a low amount of LPS (0.5 g/ml) for indicated times. Two
increased doses of secondary LPS (4.5 g/ml or 9.5 g/ml as indicated) were administered for 2.5 hours to
unwashed cultures, prior to assay. 3% agarose gel was used to resolve the RT-PCR products.
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Pol II Pausing and the P-TEFb:NELF Axis Contribute to Differential
Transcriptional Shutdown of IL1B and TNF
Pol II recruitment and pre-initiation complex assembly at IE gene promoters has
recently been associated with the presence of pre-bound, paused, Pol II (Gilchrist et al.,
2010; Gilchrist et al., 2008; Guenther et al., 2007; Kininis et al., 2009; Min et al., 2011;
Muse et al., 2007; Rahl et al., 2010; Zeitlinger et al., 2007). These genes are associated
with immediate responsiveness to stimuli, with rapid expression dependent on the release
of Pol II from its pre-induced paused state (Wu and Snyder, 2008). In this way, preloaded polymerases likely facilitate synchronized and rapid transcription of IE genes.
Since the il1b and tnf genes are transcribed almost instantly in activated monocytes, Pol
II enrichment on their promoters was examined. In agreement with a previous report for
murine macrophages (Adelman et al., 2009), TNF exhibited a significant Pol II presence
approximately 50 bp downstream of the TSS in resting THP-1 cells and human primary
macrophages (Figure 11). Surprisingly, less preloaded Pol II was detected on IL1B than
on TNF in unstimulated monocytes. LPS activation caused increased levels of Pol II
signal at the promoter proximal region and throughout the transcribed regions of both
genes, consistent with elongating Pol II. Following cell activation, a large increase of
paused Pol II at the IL1B promoter was evident in all three cell types (Figure 11). A more
precise fragmentation of genomic DNA and appropriate design of qPCR amplicons are
vital components of ChIP studies that influence the final resolution of the enrichment
data. My initial ChIP experiments using a sparsely designed qPCR amplicons yielded
useful and consistent information about the kinetic associations of various molecules but
lacked the spatial resolution of their binding. Figure 14 shows a few samples of low-
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resolution ChIP experiments used to detect recruitment of various factors to the IL1B and
TNF genes.

Figure 14. Low resolution ChIP profiles for IL1B and TNF.
Illustrated are low-resolution ChIP profiles for Pol II S5P CTD, and the transcription elongation factors
NELF and P-TEFb. Association of these individual molecules with the IL1B and TNF was measured at
indicated LPS treatment time points (0h-black, 0.5h-red, 5h-green). These data can be compared to another
independent experiment (Figure 17) that was executed using high-resolution primers depicted in Figure
15.

In order to improve the spatial data quality I designed a new set of high-density
qPCR amplicons that selectively target the promoter proximal region of IL1B and TNF
genes (Figure 15). As Figure 16 illustrates, the sonication method used in this study
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yielded DNA fragments with average length of 250-300 bp. Statistical evidence, as well
as experimental testing revealed that such fine chromatin fragmentation and appropriate
size of qPCR amplicons provide sufficient resolution for qPCR-ChIP analysis used in this
study (Xie et al., 2008).

Figure 15. High-density qPCR-ChIP amplicons encompassing the promoters of the IL1B and TNF
genes.
Illustrated is a series of qPCR amplicons, average length of 80 bp, designed for high resolution ChIP
analyses.

Figure 16. Analysis of the chromatin fragmentation.
Shown is a 1.5% agarose gel analysis of the sonicated genomic DNA isolated from THP-1 cells. The DNA
fragments obtained by this sonication method have an average length of 250-300 bp.
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Figure 11 revealed a differential spatial distribution of bound Pol II complexes
for IL1B vs. TNF, represented by two promoter-proximal peaks located approximately
150 base pairs apart for IL1B, and a single peak for TNF. The single Pol II peak on TNF
(centered at +57) and the first on IL1B (centered at +36) map near the TSS. This is
consistent with a paused polymerase (Core and Lis, 2008). Analysis of TBP revealed an
expected peak upstream of the Pol II complexes located to the TATA box of both genes.
Differential amounts of TBP binding between IL1B and TNF in resting and induced cells
agrees with and further supports differential Pol II pre-association for these genes
(Figure 17). TNF contains significant amount of pre-bound TBP in resting monocytes
and its levels further increase upon LPS stimulation. On the other hand IL1B lacks prebound TBP and its de novo recruitment is primarily dependent upon LPS stimulus
(Figure 17).
JunB, an IE gene known to have pre-associated promoter-proximal Pol II (Aida et
al., 2006; Fujita et al., 2009; Muse et al., 2007) and HIST1H4K, encoding a constitutively
expressed “housekeeping” gene, Histone 4, whose Pol II levels remain constant in resting
and LPS treated THP-1 cells serve as controls (Figure 18).
During induction of IE genes, Pol II transitions from paused into an elongating
polymerase in order to generate mRNA intermediates. An actively elongating Pol II is
associated with characteristic post-translational modifications and a presence of unique
proteins. I have analyzed several of the distinguishing features in order to define changes
that correspond to the LPS induced release of paused Pol II in stimulated monocytes.
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Figure 17. Distribution of factors relevant to differential transcriptional regulation.
ChIP for factors related to Pol II initiation and elongation at IL1B and TNF loci in THP-1 cells was
measured at distinct time points in resting (black), 1h (red) and 5h (green) LPS stimulated THP-1 cells.
Enrichment profiles for TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II (using
alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom panels) experiment
represents a 1-hour time point, in which THP-1 cells were pre-treated with the P-TEFb inhibitor 5,6dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS. Data used for
generation of this figure are presented in Appendix C.
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Figure 18. ChIP analysis for Pol II enrichment at control genes JUNB and HIST1H4K.
Pol II occupancy kinetics on JUNB and HIST1H4K genes in resting (black), 1h (red), and 5h (green) LPS
stimulated THP-1 cells. Data (upper panels) used to generate Pol II kinetic profiles are shown in the lower
panels.

The carboxy-terminal domain (CTD) of the RPB1 subunit of mammalian Pol II
containing 52 tandem heptapeptide repeats with the consensus sequence YSPTSPS, was
demonstrated to be differentially phosphorylated in paused vs. actively elongating Pol II.
Phospho-serine 5-modified CTD (S5P) locates primarily to the upstream regions of genes
as part of engaged, but stalled, Pol II. The cyclin-dependent kinase 7 (CDK7) component
of the general transcription factor TFIIH mediates this phosphorylation (Egloff and
Murphy, 2008), which aids in the process of methylguanosine cap addition to the 5’ end
of nascent mRNAs (Brookes and Pombo, 2009). I observed that the enrichment of S5P
polymerase is confined to the 5’ promoter proximal regions and decreases throughout the
gene bodies of IL1B and TNF (Figure 17). S5P Pol II ChIP also revealed two 5’ proximal
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peaks, supporting the presence of two Pol II complexes at the IL1B promoter.
Phosphorylated CTD serine 2 (S2P) marks elongating polymerases and mediates the
recruitment of various factors responsible for proper mRNA co-transcriptional
processing, including splicing and 3’ poly-A addition (Buratowski, 2003). Pol II S2P
ChIP confirmed the presence of elongating polymerase in LPS stimulated monoctyes,
having a characteristic enrichment profile in which the signals increased towards the 3’
end of both genes. Negative elongation factor (NELF) interacts with paused polymerases
and contributes to stalling by a proposed interaction with nascent RNA emerging from
Pol II via its RNA recognition motif (Gilchrist et al., 2008; Wu et al., 2003; Yamaguchi
et al., 2002). The negative effects of NELF are relieved by positive transcriptionelongation factor-b (P-TEFb), a complex of CDK9 and cyclin T1. By simultaneously
phosphorylating NELF and the S2P CTD, signal dependent recruitment of PTEF-b leads
to Pol II release from a paused state into one of elongation during pro-inflammatory
responses in murine macrophages (Hargreaves et al., 2009). Figure 17 shows kinetic
profiles for various indicators of transcription elongation following LPS treatment of
THP-1 cells. Increased binding of NELF to paused Pol II at the TNF promoter is
diminished within an hour of LPS stimulation. As induced transcription concludes,
around five hours post stimulation, NELF binding to TNF returns to pre-stimulation
levels. NELF ChIP for the IL1B promoter revealed a distinct binding pattern with
increased enrichment values at later time points. I did not see significant NELF
enrichment in unstimulated cells. Although surprising at first, this supports the low level
of paused Pol II in resting cells, and its existence in LPS stimulated monocytes. P-TEFb
is coordinately recruited to the promoters of both genes. Treatment of cells with the
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P-TEFb inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) caused an
increase in Pol II at the proposed pause sites, as confirmed by an alternative Pol II
antibody (8WG16), confirming the significance of P-TEFb in inducible control of IL1B
and TNF (Figure 17). It has been reported that the 8WG16 antibody was specifically
designed for detection of non-S2P phosphorylated CTD tail of Pol II (Brookes and
Pombo, 2009). My data correspond to an expected 8WG16 ChIP enrichment profile for
the paused genes with a peak at the promoter proximal region, which drops off towards
the 3’ end (Figure 17). Kinetic differences in P-TEFb recruitment to IL1B vs. TNF were
also observed in LPS treated monocytes. In contrast to TNF, a rapid P-TEFb recruitment
is prolonged (although decreased) on IL1B at 5 hours post stimulation. This provides an
explanation for the delayed/sustained phase of IL1B expression as compared to that of
TNF. The data argue for a kinetic interplay between positive (P-TEFb) and negative
(NELF) pausing factors that may contribute to the differential post-induction decrease
and shutdown of these two immediate-early genes. ChIP analysis of Pol II dynamics was
also expanded to the murine il1b and Tnf genes. Similar profiles of positive and negative
elongation factors and the Pol II modifications were observed for RAW264.7 cells
(Figure 19) as well as bone marrow derived macrophages (BMDM) (Figure 20). As
revealed in steady state mRNA analysis, the initial phase of Il1b and Tnf transcription is
prolonged (Figure 7). Since the Pol II binding profiles mimic this transcriptional
phenomenon, the transient nature of Pol II enrichment in these cells is less apparent
(Figure 19, 20). I observed that Pol II is pre-loaded on Tnf in similar fashion as in its
human counterpart. Following LPS treatment, rapidly recruited P-TEFb induces Tnf
elongation by inducing NELF discharge and S2P of Pol II CTD.
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Figure 19. Average profiles of factors relevant to differential transcriptional regulation in LPStreated RAW264.7 cells.
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells was
measured at distinct time points in resting (black), 1h (red) and 5h (green) LPS stimulated THP-1, cells.
Enrichment profiles for Pol II, TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II (using
alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom-most panels)
experiment represents a 1-hour time point, in which RAW264.7 cells were pre-treated with the P-TEFb
inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS. Data used
for generation of this figure are presented in Appendix D.
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Figure 20. Average profiles of various factors relevant to differential transcriptional regulation in ex
vivo-differentiated LPS-treated BMDM.
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells was
measured at distinct time points in resting (black), 4h (yellow) and 24h (blue) LPS stimulated ex vivodifferentiated BMDM. Enrichment profiles for Pol II, S5P CTD Pol II, S2P CTD Pol II, and P-TEFb are
shown. The bar graph ChIP enrichment data used for generation of this figure are presented in Figure 60.
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Consistent with the THP-1 study, murine Il1b does not contain NELF-mediated
paused Pol II complex in resting monocytes, and its induction relies on the de novo
recruitment of Pol II. The characteristic peak of Pol II enrichment in the vicinity of TSS
in LPS stimulated cells indicates a presence of rate limiting step controlling the release of
stalled polymerase. As reported for THP-1 cells, P-TEFb mediates this transition in
murine monocyte/macrophages (Figure 19, 20).

LPS Triggers a Double Pol II Pause on IL1B
Various ChIP binding profiles including total Pol II, S5P CTD Pol II, NELF and
P-TEFb collectively revealed two pausing sites near the IL1B gene promoter. This
prompted investigation of whether these two complexes are associated with either short
aborted transcripts, or Pol II dwelling. High-density amplicons designed for ChIP
(Figure 15) were used for RT-qPCR amplification of random primer-generated cDNA
samples from resting and stimulated monocytes. Genomic DNA was used for the analysis
of primer pair PCR efficiency (Figure 21). This technique provided sufficient resolution
for measuring transcriptional activity of Pol II within the observed Pol II ChIP peaks.
Amplicons specific for the DNA upstream of the TSS served as controls, registering
negligible signals. Semi-quantitative transcription profiles revealed peaks of short
transcripts corresponding to the sites of engaged, but stalled, Pol II (Figure 22). These
data represent appropriate measurements of nascent transcript production by Pol II, as
they convey consistent inducible and temporal expression patterns (Figure 22, upper
panels). Production of these RNA intermediates is sensitive to inhibitor treatments
(Figure 22, lower panels).

64

Positions relative to TSS
Figure 21. Analysis of promoter proximal qPCR amplicon efficiency.
Genomic DNA from THP-1 cells was used to determine the amplification efficiency of a series of primers
designed for ChIP-qPCR analysis as well as random primer generated cDNA analysis. For this analysis 10% of
chromatin used for antibody precipitation, equal to 4x105 THP-1 cells was used.

The inhibitors used for this experiment abolish activation of the transcription
factors NF-B (MG 132) and C/EBPβ (U0126). While NF-B is the primary activator of
TNF, both NF-B and C/EBPβ are required for efficient transcription of the IL1B gene, which
is consistent with the inhibitor effects on mRNA levels shown in Figure 22. In agreement
with observed Pol II ChIP data, the presence of basal transcription for TNF in unstimulated
monocytes was further confirmed utilizing this technique. Data sets for TNF closely
resembled the classically paused JunB gene (Figure 22). Since the second Pol II peak on IL1B
was not associated with a significant level of nascent RNA signal, it is possible that these Pol
II complexes represent resting/dwelling polymerases, and not the presence of two
transcription initiation sites. Contrary to the inducible IL1B, TNF, and JunB profiles, the
control HIST1H4K gene transcript amplification shows constitutive expression (Figure 22).
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Figure 22. Steady-state mRNA kinetics for IL1B, TNF, and control gene transcripts in LPS
stimulated THP-1 cells.
cDNA prepared form THP-1 cells, stimulated with LPS at different time points and/or pre-treated with
various inhibitors was subjected to qPCR analysis using high-resolution primers spanning the promoter
proximal regions of IL1B and TNF. Transiently induced JUNB and constitutively expressed HIST1H4K
were used as controls for this experiment. Black bar graphs located in the upper corners of the diagrams
represent magnification of mRNA in unstimulated THP-1 cells due to the fact that their levels are
extremely low (TNF) or absent (IL1B) in comparison to the 1.5h LPS activated monocytes. The inhibitors
MG132 (blue bars) and U0126 (yellow bars) were used to inhibit the activation of transcription factors NFB and C/EBPβ. While NF-B is the primary activator of TNF, both NF-B and C/EBPβ are required for
efficient induction of the IL1B gene. The red bars represent samples that were pre-treated with the P-TEFb
inhibitor DRB, which interferes with the transition of Pol II into transcription elongation.
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Pol II S2P CTD Differentially Influences IL1B and TNF Endotoxin Tolerance
Some IE cytokines have been associated with inhibitory mechanisms that prevent reexpression upon secondary endotoxin stimulus (Foster et al., 2007). Prior attempts to
explain this phenomenon by transcription suppression have failed to note that the
expression profiles for these genes are highly transient. If transcription following
secondary stimulation is not analyzed within a short time frame, the re-stimulation
properties can be overlooked. In addition, usage of inconsistent doses of secondary LPS
and washing of cells between primary and secondary endotoxin challenge may result in
experimental variability and induce physiological stress to highly sensitive cells,
respectively. In my experiments, Western blot analysis demonstrated that secondary
stimulation of IL1B resulted in expression of 30 KDa proIL-1 precursor protein (Figure
23). Strikingly, these results recapitulate an earlier report that in vivo injection of a
sublethal dose of LPS into mice resulted in TNF, but not IL-1 tolerance, as assayed by
kinetic protein analysis of serum (Zuckerman et al., 1991).

Figure 23. Western blot depiction of the 30 KDa proIL-1 precursor protein.
THP-1 cell were initially stimulated with 1 g/ml of LPS for indicated times and an equal dose of
secondary LPS was administered for 3 hours to unwashed THP-1 cultures, prior to cell harvest and analysis
of the proIL-1 expression. The chemiluminescent detection of secondary antibody was assayed using a
molecular dynamics Typhoon 8600 phosphor/fluorescence imager.
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Similarly, steady-state kinetic mRNA secondary stimulation revealed that IL1B
transcription is not completely desensitized/tolerized (Figure 7). ChIP revealed a
somewhat decreased, but significant, amount of Pol II at the promoter-proximal regions
of both genes in 13 and 25 hour stimulated monocytes, with decreased signal downstream
of the pause sites (Figure 24, 25). At 25 hours, Pol II occupancy within the gene body
was slightly higher for IL1B, likely explaining the sustained transcriptional profile of the
gene. NELF was co-localized with promoter bound Pol II on both genes (Figure 24). My
data reveal that upon secondary stimulation, P-TEFb is re-recruited to the IL1B promoter,
resulting in resumption and maintenance of transcriptional elongation by Pol II. This is in
contrast to tolerized TNF, in which P-TEFb recruitment and S2P CTD levels are not
increased in LPS re-stimulated cells (Figure 24).
Re-stimulation experiments carried out at 13 hours revealed a similar but
decreased response to a secondary LPS stimulus. This suggests that IL1B undergoes a
degree of decreased LPS responsiveness within the first 13 hours of initial stimulation
(Figure 25). As described in the Introduction, P-TEFb mediated phosphorylation of
serine 2 within the CTD of elongating Pol II promotes recruitment of various splicing
factors to ensure proper nascent mRNA processing. The fact that P-TEFb is recruited to
IL1B and not TNF during secondary LPS exposures, prompted us to examine the integrity
of transcripts produced in the reactivated THP-1 cells.
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Figure 24. ChIP re-stimulation experiments at 25 hours.
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II on IL1B and TNF during secondary LPS stimulation
of THP-1 cells. The solid lines represent primary and dotted lines secondary LPS treatment of THP-1 cells
at indicated times. Thin gray lines denote 1h LPS reference. Gene landmarks (gray bars) reveal the location
of an additional important NF-B binding site (-300 bp) for IL1B. Solid blue lines denote ChIP data for
primary LPS challenge harvested at 25 hours post simulation. Dotted blue lines show ChIP data for THP-1
cells that were initially treated for 24 hours with LPS, and subjected to a re-stimulation for an hour prior to
their fixation and harvest. Equal dosage of LPS (1 g/ml) was used in both, primary and secondary
stimulation experiments. Data used for generation of this Figure are presented in Appendix E.
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Figure 25. ChIP re-stimulation experiments at 13 hours.
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II on IL1B and TNF during secondary LPS stimulation
of THP-1 cells. The solid lines represent primary and dotted lines secondary LPS treatment of THP-1 cells
at indicated times. Thin gray lines denote 1h LPS reference. Gene landmarks (gray bars) reveal the location
of an additional important NF-B binding site (-300 bp) for IL1B. Solid blue lines denote ChIP data for
primary LPS challenge harvested at 13 hours post simulation. Dotted blue lines show ChIP data for THP-1
cells that were initially treated for 12 hours with LPS, and subjected to a re-stimulation for an hour prior to
their fixation and harvest. Data used for generation of this Figure are presented in Appendix E.
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Figure 26. qPCR-amplified random primer generated cDNA levels for IL1B and TNF following restimulation.
Primary stimulations are labeled as black bars while secondary treatments are shown as gray bars. Restimulation time points are indicated above the respective gray bars (0.5h, 1.5h, and 3h). Equal dosage of
LPS (1 g/ml) was used in all treatments. The qPCR data are normalized to the endogenous 18srRNA
levels.

The analysis of a random primer (instead of polyA) generated cDNA products
revealed a minor increase of TNF mRNA in secondary stimulated monocytes (Figure
26). These messages are likely representing incompletely processed primary TNF
transcripts that are generated by the low levels of P-TEFb deficient transcribing Pol II. I
propose that the gene specific recruitment of P-TEFb serves as a regulatory step
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mediating the escape form endotoxin tolerance. This mechanism ensures proper IL1B
mRNA polyadenylation and processing, which is deficient during the re-stimulation of
TNF gene. My results indicate that the low levels of sustained IL1B expression may
maintain the gene sufficiently competent for secondary re-induction. These data argue
that secondary induction of IL1B is a physiologically significant phenomenon that further
distinguishes it from TNF.
Contrary to previous studies (Chan et al., 2005; Foster et al., 2007; Yoza et al.,
2002) our re-stimulation experiments were conducted without washing of the monocytes
between primary and secondary endotoxin challenge. Since some of these reports argued
that both TNF and IL1B are incapable of re-activation, I decided to repeat their
experimental set up and conduct a set of experiments in washed THP-1 cultures. As
Figure 27 demonstrates, washing of monocytes prior to the secondary LPS treatments
decreased expression of IL1B. These experiments suggest that the washing step may
impede function of cell surface TLR4-mediated receptor signaling.

Figure 27. Washing of cells prior to re-stimulation abolishes IL1B expression.
Cell cultures were initially stimulated with a low amount of LPS (0.5 g/ml) for indicated times. Two
increased doses of secondary LPS (4.5 g/ml or 9.5 g/ml as indicated) were administered for 2.5 hours to
washed or unwashed cultures, prior to assay. Three percent agarose gel was used to resolve the RT-PCR
products.
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LPS Stimulation of Monocytes Results in Dynamic Changes in Nucleosome
Positioning and Modification on IL1B and TNF
Nucleosome positioning plays a critical role in controlling the accessibility of
promoters for transcription machinery, and genome-wide studies have shown that
Drosophila and human promoters are commonly devoid of nucleosomes (Mavrich et al.,
2008; Schones et al., 2008). Stalled Pol II can serve as a physical barrier by preventing
promoter-proximal nucleosome assembly and formation of repressive chromatin, thus
enabling explicit gene regulation (Gilchrist et al., 2010). Additionally, it has been
demonstrated that CpG-islands near gene promoters prevent nucleosome deposition and,
therefore, can influence the competence of transcriptional responsiveness to TLR4
stimulus (Ramirez-Carrozzi et al., 2009). It is interesting to note that IL1B and TNF do
not contain a significant presence of CpG-islands in the vicinity of their promoters. To
address the question of chromatin influence on these two genes, promoter nucleosome
occupancy in resting and stimulated THP-1 monocytes, as well as a cell line that fails to
express either IL1B or TNF (HEK293 pre-neuronal (Shaw et al., 2002)) and one that
constitutively expresses only TNF (HUT102 cutaneous T lymphocyte), were examined
by core histone 3 (H3) ChIP (Gilchrist et al., 2008; Schones et al., 2008). This provided
sufficient resolution to obtain enrichment profiles for phased nucleosomes (Figure 28).
Here I report +1 nucleosomes on both genes approximately 200 bp downstream of TSS.
A similar observation was reported for the Hsp70 promoter in Drosophila (Petesch and
Lis, 2008). The distribution of more weakly positioned nucleosomes, upstream of TSS
was unique to each of the genes. I observed a significant depletion of promoter bound
nucleosomes in 1 hour-stimulated monocytes, similar to that reported for activated genes
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in yeast (Lee et al., 2004). The extent of nucleosome depletion was reduced in cells
pretreated with the inhibitors selective for transcription factors associated with one or
both of these genes (Figure 28).
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Figure 28. Nucleosome positioning dynamics during IL1B and TNF induction. Depicted are spatial and
kinetic histone 3 (H3) ChIP data for IL1B and TNF in resting (black), 1h (red), and 5h (green) stimulated
THP-1 cells, as well as control Hut102 (pink line) and HEK293 (blue line) cells. Key nucleosomes are
designated by position relative to the TSS (-2, -1, +1). The blue dotted line represents H3 ChIP for THP-1
cells pre-treated with the NF-B inhibitor MG132 and the yellow dotted line denotes the U0126 (C/EBPβ
inhibitor) treated THP-1 cell samples. Data used for generation of this Figure are presented in Appendix F.
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I argue that this process is stimulation dependent, requiring specific factor
recruitment. It is noteworthy that the IL1B nucleosome displacement is sensitive to both
inhibitors, whereas TNF is almost exclusively affected by MG132, suggesting that
C/EBP is specific to IL1B. Five hours post-stimulation, as the Pol II recruitment levels
decline, depleted nucleosomes recovered, approaching initial enrichment levels for the +1
nucleosome of TNF. In contrast, IL1B nucleosome depletion only exhibited a partial
recovery. In addition, pre-treatment of cells with either inhibitor resulted in a striking
increase in the -1 IL1B nucleosome, revealing an additional distinction from TNF. The
presence of a uniquely phased -1 nucleosome within the NFR has been suggested to
inhibit Pol II recruitment (Gilchrist and Adelman, 2012; Jiang and Pugh, 2009), but to
our knowledge this is the first report indicating its role affecting inducible IE activation in
human immune cells and may reflect loss of an important priming function for TNF.
Figure 29 illustrates that the nucleosome eviction at IL1B and TNF promoter regions is
likely mediated by the ATP-dependent histone remodeler SNF2/BRG1. ChIP data
reveal a rapid recruitment of BRG1 to the promoters of both IE genes within 30 minutes
of LPS treatment. The inducible BRG1 binding was prominent in vicinity of the IL1B and
TNF promoters as compared to the structural part of the genes (Figure 29).
In HEK293, IL1B and TNF nucleosomes were similarly positioned to those in
THP-1, exhibiting higher levels, especially for the -1 nucleosome. Nucleosomes were
similarly more abundant than in THP-1 for IL1B in Hut102, with higher levels for -2 and
+1 nucleosomes. The constitutive expression of TNF in Hut102 revealed a depleted
profile almost identical, but slightly higher, than that for 1 h stimulated THP-1 cells.
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Figure 29. Nucleosome eviction at the IL1B and TNF promoter regions is likely mediated by the
ATP-dependent histone remodeler SNF2/BRG1.
Spatial and temporal occupancy of the SNF2/BRG1 complex at the IL1B and TNF genes was analyzed at
indicated time points (0h, 0.5h 1h, 3h, 6h) following LPS treatment.

To further understand the processes regulating the initially poised, but repressed,
gene architectures and LPS induced transcriptional profiles, spatial-temporal distribution
of several chromatin marks on IL1B and TNF was investigated (Figure 30).

LPS

activation induced changes in nucleosome marks on these two genes. I observed the
presence of high levels of H3K4me3 and low levels of H3K27me3 (Akkers et al., 2009)
in monocytes that likely contribute to activity.
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Figure 30. Histone modifications at IL1B and TNF in THP-1, Hut102, and HEK 293 cells.
Depicted are spatial and kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and H3K27me3
for IL1B and TNF in resting (black), 1h (red), and 5h (green) stimulated THP-1 cells, as well as control
Hut102 (pink line) and HEK293 (blue line) cells. All panels are similarly scaled with respect to spatial
distribution along each gene, permitting comparative localization. Data used for generation of this Figure
are presented in Appendix G.
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The initial permissive levels of H3K4me3 restricted to the vicinity of + 1
nucleosomes do not show a significant increase during the initial one hour LPS treatment.
To our surprise, enrichment of this mark revealed delayed kinetics and follows Pol II
recruitment as shown by an increase at 5 hours post-stimulation. Higher levels of
H3K4me3 at 5 h remain mostly focused at the promoter for IL1B, but spread throughout
the downstream coding region of TNF. The distinct positional effect of H3K4me3 at the
promoter versus the downstream coding region of genes has previously been observed for
other genes (Barski, et al., 2007), and may be critical for differences between IL1B and
TNF. Examination of other nucleosome marks for these two genes revealed that the
relative level of H3K9ac within the coding region is relatively higher for IL1B than TNF
at 5 h post LPS. Taken together, the relative levels of H3K4me3 and H3K9ac
downstream of the TSS suggest a possible association with post-stimulatory tolerance for
TNF. It is important to note that prior to stimulation, both genes are associated with low
levels of H3K9ac that might play an additional role in maintaining the IL1B and TNF
promoters in a transcriptionally poised state. The suppressive effect of the polycomb
group proteins mediated by H3K27me3 directed transcriptional silencing is reversed by
the H3K27 specific demethylase JMJD3 during macrophage inflammatory responses (De
Santa et al., 2007). Loss of this repressive chromatin mark in Drosophila and embryonic
stem cells, was shown to result in an increase in H3K27 acetylation, which was mediated
by the acetyltransferase (HAT) activity of p300 and CBP (Pasini et al., 2010; Tie et al.,
2009). Our observations of depleted levels of H3K27Me3 encouraged us to examine the
kinetic changes in H3K27Ac deposition and binding patterns of p300 on IL1B and TNF.
As revealed in Figure 31, acetylation at lysine 27 was associated with an LPS-dependent
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increase at the -2 nucleosomes, while a transient decrease was observed in H3K27Ac on
downstream nucleosomes.

Figure 31. Spatial-temporal distribution of H3K4me1 at IL1B and TNF in THP-1 cells.
Depicted are spatial and kinetic ChIP profiles for H3K27ac for IL1B and TNF in resting (black), 1h (red),
and 5h (green) stimulated THP-1 cells. The additional vertical gray bar located at the -3000 position
upstream of TSS marks the IL1B enhancer region. Data used for generation of this Figure are presented in
Appendix G.

In agreement with these changes, p300 was transiently recruited upstream of the
IL1B and TNF promoters by LPS (Figure 32). The Pol II elongation footprint marked by
H3K36me3 (Henikoff and Shilatifard, 2011) revealed a consistent LPS-induced transient
enrichment pattern increasing towards the 3’ end of both genes (Figure 30). In contrast to
IL1B, significant levels of H3K36me3 were detected on the TNF locus in un-stimulated
monocytes, further confirming constitutive basal activity. The spatial distribution of
chromatin modifications at the IL1B and TNF loci were also assessed for Hut102 and
HEK293 cells (Figure 30). Pol II levels and chromatin marks for TNF in Hut102 are
consistent with the active transcription previously reported (Kronke et al., 1988), whereas
IL1B is repressed in these cells and does not exhibit any positive indicators for either
gene, while revealing inhibitory H3K27me3, absent in THP-1 (Figure 30).
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Figure 32. ChIP analysis of p300 association at the IL1B and TNF genes.
Shown is the LPS inducible association of p300 with the TNF and IL1B promoters as well as the
IL1B enhancer. The NF-B inhibition using inhibitor MG132 abolishes p300 recruitment to both IE
genes.

TNF in Hut102 reveals significant levels of both H3K4me3 and H3K27me3, the
so-called “bivalent” mark (Akkers et al., 2009), indicative of developmental, rather than
transient IE induction, possibly responsible for the constitutive expression of this gene in
these HTLV-1 infected malignant T cells. HEK293 does not show positive indicators for
either gene, exhibiting non-bivalent inhibitory H3K27me3 on both. The inhibitory
H3K27me3 extends throughout the entirety of both genes, but appears to be more focused
over the coding region of TNF, while for IL1B, there is a greater level far upstream over
the potent LPS enhancer near -3000, which binds C/EBP (Shirakawa et al., 1993). The
analysis of spatial distribution of chromatin modifications at the IL1B and TNF locus was
extended to the osteosarcoma MG 63 cell line. My data set (represented in the
comprehensive Figure 33) reveals that MG 63 do not support expression of either one of
the two IE genes.
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Figure 33. Summary of the histone modification ChIP profiles for IL1B and TNF in THP-1, HEK
293, Hut102, and MG63 cells.
Illustrated are the summary profiles comparing nucleosome modifications for resting (black), 1h (red), and
5h (green) LPS-treated human THP-1 cells with untreated HEK293 pre-neuronal cells (pink line), Hut102
cutaneous T lymphocytes (orange line), and MG63 osteoblastic cells (blue line). Depicted are spatial and
kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and H3K27me3, H3K9me1, H3K27ac,
and H3K4me1 for IL1B and TNF. All panels are similarly scaled with respect to spatial distribution along
each gene, permitting comparative localization. Data used for generation of this Figure are presented in
Appendix G.
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Active chromatin marks and levels of Pol lI in MG 63 cells largely differ from
those of THP-1 monocytes. The inhibitory chromatin marks H3K9me1 and H3K27me3
(Kouzarides, 2007) are prevalently distributed along the IL1B locus, further confirming
its transcriptional suppression in MG 63 cell line.
Lastly, the comparison of chromatin levels among the different cell lines enabled
us to confirm that H3K9me1 is a likely indicator of transcriptional inactivation. Since
IL1B and TNF are repressed in resting monocytes, I inquired whether H3K9me1
contributed to the regulation of induction or the switching-down/off of these IEs. I
observed that the high levels of H3K9me1 distributed throughout IL1B and TNF in
resting monocytes were rapidly lost following LPS treatment and remained low even
during the transcriptional shut-down, which was opposite to the kinetic pattern of
H3K9ac ChIP (Figure 33). I conclude that the TLR4 dependent activation of IL1B and
TNF caused replacement of the repressive H3K9me1 mark with a transcriptionally
permissive acetylation (Gomes and Espinosa, 2010), likely contributing to the expression
of both genes.
Spi1 Mediates Monocyte-specific IL1B Expression
The regulatory sequences driving IL1B and TNF expression contain numerous
binding sites for various transcription factors that cooperatively contribute to the precise
temporal and cell-type specific expression. Evaluation of the spatial-temporal distribution
of selected transcription factors revealed that IL1B is dependent upon a different set of
regulators than TNF. A major factor involved in genome-wide maintenance of the
macrophage lineage is the ETS domain DNA binding factor Spi1 (Lawrence and Natoli,
2011). In particular, recent genome-wide studies revealed a constitutive association of
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Spi1, often with other signal inducible factors, at LPS responsive enhancers in murine
macrophages (Ghisletti et al., 2010; Heinz et al., 2010).
Inducible IL1B transcription depends on a poised monocyte-specific enhancer
that requires cooperative association of Interferon regulatory factor 8 (IRF8), Spi1, and
non-tyrosine phosphorylated (NTP)-Stat1 (Unlu et al., 2007). In addition, Spi1 binding is
also required at the IL1B promoter (Kominato et al., 1995). Consistent with earlier
studies, ChIP revealed a robust constitutive association of Spi1 at the IL1B promoter and
enhancer that persisted for an extended time post induction (Figure 34). In contrast, Spi1
was significantly less abundant at the TNF promoter (Figure 34).

Figure 34. ChIP analysis of Spi1 binding to the IL1B promoter and enhancer regions.
Spi1 is constitutively present at the IL1B promoter (peaking at position -91) and enhancer (as measured at
position -2976) regulatory regions (black bars). Its binding persists for up to 5 hours post LPS stimulation
(pink bars). Spi1 is significantly less abundant at the TNF promoter.

I hypothesized that in addition to its role priming enhancers, Spi1 binding at the
IL1B promoter mediates the cell-type restricted transcriptional competency of this
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pro-inflammatory gene. To examine the role of this “pioneer factor” during IL1B
induction, transient transfection studies were carried out in HEK293 cells, which do not
transcribe IL1B. Initial screens for transcription factor expression levels revealed the
absence of Spi1 in these cells, as compared to THP-1 monocytes (Figure 35A). Since
HEK293 do not express LPS-sensing TLR4 receptor, co-transfection of TNF receptorassociated factor 6 (TRAF6) was used as a dominant-positive LPS surrogate in these cells
(Figure 35B, illustration) (Wang et al., 2006).

A

B

Figure 35. RT-PCR analysis of the transcription factor expression levels in HEK 293 cells.
(A) The 3% agarose gel showing the RT-PCR products for transcription factors in HEK293 and THP-1
cells. The monocyte specific factors Spi1 and IRF8 are not expressed in HEK 293 cells. An additional
panel displays ectopic expression of Spi1 in transfected HEK293. (B) Compariative Illustrations showing
ectopic transfection of TRAF6 being used as a surrogate to induce the signaling, resembling LPS activation
of monocytes. TRAF6 is a signal transducer, which acts downstream of the TLR4 receptor signaling
pathway.

Figure 36 shows that an IL1B reporter vector (XT-Luc) was potently up-regulated
by Spi1 in combination with IRF8, a factor important for full IL1B activity in monocytes
(Unlu et al., 2007) that is absent in HEK293, and dominant-positive TRAF6.
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Figure 36. Spi1 is critical for IL1BXT-Luc reporter activity in HEK293 cells.
Transcription factors associated with IL1B activation were ectopically transfected into HEK 293 cells
together with IL1BXT Luciferase reporter. Binding of the ectopically transfected transcription factors
causes activation of IL1BXT-luc reporter, which is represented as RLU (relative luciferase units). The
effect of individual and combined transcription factors is compared to an empty vector pCDNA3.1 (vector)
transfected samples. The dnSpi1 denotes a dominant negative Spi1 deletion protein lacking a critical Nterminal trans-activation domain. The amount of the total transfected DNA was equal in all wells. The data
are representative of three independent experiments.

Spi1 function requires the integrity of its N-terminal TBP Binding Domain
(TBD), as revealed in transient transfection using HeLa cells (Kominato et al., 1995). In
agreement, ectopic expression of a dominant-negative Spi1 mutant (dn/Spi1), containing
only the Spi1 DNA binding domain, reduced XT-Luc activity to background levels.
Analysis of the endogenous IL1B mRNA by RT-PCR (Figure 37A, B) as well as qPCR
(Figure 38A, B) in HEK293 transfected with the same factors supported the luciferase
results as well as the critical role of Spi1 for IL1B induction (Figure 38).

90

A

B

Figure 37. Ectopically transfected transcription factors induce endogenous IL1B expression in HEK
293 cells.
Represented are the IL1B RT-PCR products isolated from HEK 293 cells that were ectopically transfected
with combinations of transcription factors Spi1 and IRF8 (A) and Spi1and C/EBP (B) co-transfected with
the LPS surrogate TRAF6. IL1B RT-PCR products analyzed by 3% agarose gel electrophoresis. The
amount of the total transfected DNA is equal in all wells. The data are representative of three independent
experiments.

A

B

Figure 38. Spi1, IRF8, and TRAF6 induce endogenous IL1B mRNA levels in HEK293 cells.
(A) Shown are qPCR experiments detecting the IL1B mRNA in HEK293 cells that were ectopically
transfected with wild type or dominant negative Spi1 and IRF8 co-transfected with the LPS surrogate
TRAF6. Figure (B) shows IL1B mRNA levels in 293 cells transfected with above mentioned factors as well
as a mutated IRF8 (IRF8Y211F). The data are normalized to the endogenous 18srRNA expression levels.
The amount of the total transfected DNA is equal in all wells. The data are representative of three
independent experiments.
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Figure 39. Spi1 does not affect the endogenous levels of TNF mRNA in HEK293 cells.
Represented is a qPCR analysis of the IL1B and TNF mRNA in HEK293 cells that were ectopically
transfected with Spi1. The data are normalized to the endogenous 18srRNA expression levels.

Figure 40. Detection of ectopically expressed Spi1 mRNA in HEK293 cells.
Shown is a 3% agarose gel of the Spi1 RT-PCR products from HEK293 cells transfected with various
combinations of transcription factors and signaling molecules. Only HEK293 cells that express the
ectopically transfected Spi1 reveal a positive RT-PCR band.

The basal level of IL1B transcription in cells transfected only with Spi1 was
radically increased by addition of IRF8 and TRAF6. IRF8 and TRAF6 alone (Figure
38A) or in combination (Figure 38B) are insufficient for IL1B activation. Substitution of
wild type with dn/Spi1 abolished IL1B expression. As Figure 38B demonstrates, IL1B
message was reduced to a lesser degree in cells transfected with dominant negative IRF8
(dn/IRF8), as previously reported (Unlu et al., 2007). In addition, TNF expression in Spi1
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transfected HEK293 was not affected (Figure 39). Control RT-PCR data revealed that
both, the wild type and dn/Spi1 are expressed in ectopically transfected 293 cells (Figure
40).
Since the N-terminal activation domain of Spi1 has been shown to directly
interact with TBP (Hagemeier et al., 1993), I wondered whether Spi1 plays a role in
recruitment of TBP to the IL1B promoter. To test this hypothesis, ChIP of IL1B was
carried out in HEK293 transfected with either wild type or dn/Spi1 in combination with
IRF8 and TRAF6. As shown in Figure 41, transfection of Spi1 and the auxiliary factors
increased occupancy of TBP at IL1B TATA box. In agreement with an increase in IL1B
transcription, I observed recruitment of Pol II to IL1B downstream of TSS, resembling a
paused polymerase, as well as to the transcribed region of the gene, consistent with
elongation. Enrichment signals for TBP and Pol II occupancy in HEK293 transfected
with dn/Spi1 were dramatically reduced (Figure 41). Transfection-induced IL1B
activation was also associated with depletion of promoter-proximal phased nucleosomes.
Figure 42 shows that full length Spi1 in combination with TRAF6 and IRF8 is necessary
for nucleosome depletion at the IL1B promoter. These data suggest that Spi1 plays a
critical role at the IL1B, but not the TNF promoter. In addition to facilitating IL1B
promoter accessibility (Marecki et al., 2004), the N-terminal TBD of Spi1 may play an
additional role in the recruitment of the general transcription machinery via TBP. Its
constitutive association at the promoter in a macrophage-restricted setting mediates IL1B
transcriptional competency as well as stimulus-responsive selective activation.
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Figure 41. The N-terminal domain of Spi1 is critical for the recruitment of TBP and Pol II to the
endogenous IL1B promoter in HEK293 cells.
Depicted are ChIP data for the ectopically expressed binding of Spi1 (top panel) along with the endogenous
binding of TBP and Pol II. HEK 293 cells were transfected with an empty vector plasmid DNA (black line)
or combination of wild type (red line) or mutant Spi1 (green line) co-transfected with IRF8 and TRAF6.
The broader distribution of the TBP enrichment peak, as compared to the THP-1 experiments (Figure 17),
is a result of a broader specificity for the antibody TFIID (TBP) sc-273, which was used for this
experiment.
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Figure 42. Spi1, co-transfected with IRF8 and TRAF6, mediates nucleosome eviction from the IL1B
gene promoter.
Shown are ChIP data for the spatial distribution of the core histone 3 (H3) along the IL1B gene promoter.
HEK 293 cells were transfected with an empty vector plasmid DNA (black line), Spi1 alone (dotted blue
line), or combination of wild type (red line) or mutant Spi1 (green line) co-transfected with IRF8 and
TRAF6. Data used for generation of this figure are presented in Appendix F.

C/EBP interaction with Spi1 mediates the LPS inducible induction of IL1B
It has been postulated that the lineage-determining factor Spi1 facilitates
formation of NFR, exposing binding sites for LPS-responsive transcription factors in
activated monocytes (Natoli, 2012). Endotoxin dependent binding of NF-B, an IE
transducer of numerous pro-inflammatory genes, has been shown to play an important
role during coordinate induction of IL1B and TNF in monocytes (Hiscott et al., 1993);
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(Collart et al., 1990). Our kinetic ChIP analyses revealed transient binding of NF-B to
both genes as early as 30 minutes post LPS treatment (Figure 35).

Figure 43. Kinetic binding of NF-B to IL1B and TNF in THP-1 cells.
Shown is the ChIP analysis for the kinetics of NF-B binding to the IL1B and TNF gene promoters. The
time points for LPS treatments are indicated above. Pre-treatment of the THP-1 cells with MG132 (1.5h
MG) and BMS-345541 (1.5h IKK) inhibitors reduced the NF-B binding to both genes. The inhibitors
were applied 2 hours prior to the 1.5-hour LPS stimulations of the THP-1 cells.

Pre-treatment of THP-1 cells with NF-B-targeted inhibitors MG132 (proteasome
inhibitor) and BMS-345541 (IB kinase inhibitor) diminished NF-B binding to both
genes (Figure 43). Consistent with the decreased NF-B binding, the mRNA levels of
both genes were significantly reduced. The mRNA expression was tested in both THP-1
as well murine RAW cells (Figure 44, 47). The precise control of cell-permeable
inhibitor addition to cells is suitable for conducting time sensitive kinetic experiments.
Earlier studies used various in vitro assays in order to demonstrate the involvement of
C/EBP during IL1B regulation (Auron and Webb, 1994; Tsukada et al., 1994).
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Figure 44. NF-B is necessary for the LPS induction of IL1B and TNF genes in THP-1 cells.
The 3% agarose gels reveal RT-PCR data for IL1B and TNF mRNA expression in THP-1 cells. DMSO,
used to resuspend the MG132 inhibitor, has no effect on the IL1B and TNF gene activation. Inhibitor was
applied 2 hours prior to LPS treatments (time points for LPS addition are indicated above the gel images).

However, ChIP permits evaluation of the in vivo binding profile for C/EBP at
IL1B and TNF regulatory regions in LPS stimulated cells. Kinetic analysis illustrates
LPS-mediated recruitment of C/EBP to the IL1B, but not to the TNF promoter (Figure
45). Inhibitor U0126 was chosen in order to selectively target the MEK1/2 pathway that
is involved in activation of C/EBP. LPS activated monocytes pre-treated with U0126
revealed decreased IL1B transcription (Figure 46, 47), consistent with reduced C/EBP
binding. TNF expression was unaffected by U0126 treatment (Figure 46, 47).
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Figure 45. LPS inducible binding of C/EBP to IL1B in THP-1 cells.
Shown is the ChIP analysis for the kinetics of C/EBP binding to the IL1B and TNF gene promoters. The
time points for LPS treatments are indicated above. Pre-treatment of the THP-1 cells with the inhibitor
U0126 for 2 hours was used in order to inhibit the C/EBP activity.

Figure 46. C/EBP inhibition decreases IL1B mRNA expression in RAW264.7 cells.
An RT-PCR analysis shows that selective targeting of MEK1/2 pathway leads to inhibition of IL1B and not
TNF mRNA expression. RAW264.7 cells were pre-treated with various concentrations of U0126 for 2
hours and mRNA levels were analyzed 1.5-hour post LPS treatment. The RT-PCR products were resolved
using 3 % agarose gel.

Transient transfection of the 293 cells was carried out in order to better define the
role of these inducible transcription factors. NF-B and C/EBP were not effective IL1B
inducers when transfected alone into 293 cells.
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Figure 47. The effects of NF-B and C/EBP inhibition on IL1B and TNF mRNA expression in
RAW264.7 and THP-1 cells.
Shown are 3% agarose gels used for RT-PCR analysis of IL1B and TNF mRNA in RAW264.7 and THP-1
cells. The cell cultures were pre-treated with NF-B (MG132) and C/EBP (U0126) inhibitors 2 hours
prior to addition of LPS.

Significant activation of IL1B was observed when the factors were transfected in
combination with Spi1. Co-expression with TRAF6 showed the strongest IL1BXT-Luc
activity (Figure 48).

Figure 48. NF-B and C/EBP cooperatively induce the ILBXT-Luc activity.
Sown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically transfected
with indicated factors. The effect of individual and combined transcription factors is compared to an empty
vector pCDNA3.1 (Vector) transfected samples. The amount of the total transfected DNA is equal in all
wells. The data are representative of three independent experiments.
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Overexpression of an IB super repressor (IBSR), (Van Antwerp et al., 1996)
considerably reduced, but did not completely abolish, IL1B activity in 293 cells
transfected with Spi1, TRAF6, and C/EBP (Figure 49A). This

argues

that

in

the

absence of NF-B, transcription of IL1B may continue due to the presence of C/EBP.
Experiments in RAW 264.7 cells further demonstrate that IBSR fully
eliminates NF-B activity without completely inactivating IL1BXT-Luc (Figure 49B).

A

B

Figure 49. Inhibition of NF-B activity does not completely abolish IL1BXT-Luc activity.
(A) Ectopic expression of IκB super repressor (IκBSR) in HEK293 co-transfected with indicated
factors. (B) IL1BXT-Luc and MHCB reporter activity in RAW264.7 transfected with IκB super
repressor (IκBSR). The amount of the total transfected DNA is equal in all wells. The data are
representative of three independent experiments.
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In addition, titration of truncated, dn/C/EBP, (Tsukada et al., 1994) in 293 cells,
confirmed a dose dependent inhibition of IL1B reporter expression (Figure 50).

Figure 50. Ectopic transfection of dnC/EBP abolishes IL1BXT-Luc reporter activity in HEK293.
Shown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically
expressing wild type or indicated amounts of the dominant negative (dn) C/EBP co-transfected with Spi1
and TRAF6. The amount of the total transfected DNA is equal in all wells. The empty vector pCDNA3.1
was used to balance the amount DNA transfected across the samples. The data are representative of three
independent experiments.

To further demonstrate the importance of NF-B and C/EBP for IL1B
induction, RAW264.7 cells were transiently transfected with modified IL1BXT-Luc
reporter harboring mutations within the essential NF-B (-300) and C/EBP (IRegion/Enhancer) binding sites. As depicted in Figure 51, disrupted binding of these two
factors severely reduced responsiveness of the IL1B reporter to LPS. Lastly, siRNA for
NF-B and C/EBP in 293 cells revealed significant reduction of IL1BXT-Luc activity
(Figure 52). IL1B expression was somewhat more sensitive to NF-B inhibition, as
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compared to that of C/EBP. In agreement with our previous results, depletion of Spi1
caused severe reduction of the IL1B reporter activity (Figure 52).

Figure 51. Mutation of the critical C/EBP and NF-B binding sites reduces IL1BXT-Luc reporter
activity.
Shown are relative luciferase data for IL1BXT-Luc reporter activity in RAW264.7 cells ectopically
transfected with the modified IL1BXT-Luc reporter harboring mutations within the essential NF-B (-300
B) and C/EBP (I c/g) binding sites. The amount of the total transfected DNA is equal in all wells.

Figure 52. siRNA mediated inhibition of C/EBP, NF-B, and Spi1 reduced IL1BXT-Luc reporter
activity in HEK293.
Shown are relative luciferase data for IL1BXT-Luc reporter activity in HEK293 cells ectopically expressing
Spi1, IRF8, and/or TRAF6. The indicated transcription factors (C/EBP, NF-B, and Spi1) were depleted
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using siRNA, which was transfected into HEK293 cells 24 hours prior to addition of Spi1, IRF8, and/or
TRAF6.

The data presented here challenge the popular notion that NF-κB is the only
critical factor affecting IL1B induction. It appears that NF-B and C/EBP cooperatively
regulate LPS induced transcription of IL1B, while expression of TNF appears influenced
primarily by NF-B.
I next explored the relationship between the factors and the dynamics of the
release of paused Pol II during transcription of IL1B and TNF. To address this question,
P-TEFb ChIP was conducted on LPS stimulated THP-1 cells pre-treated with inhibitors
targeting selected transcription factors. As shown in Figure 53, inhibition of NF-B
resulted in significant depletion of P-TEFb recruitment to both genes. This observation is
consistent with reports indicating that NF-B phosphorylated at serine 276 interacts with
the active P-TEFb complex consisting of bromodomain protein 4 (BRD4) and cyclindependent kinase 9 (CDK9) (Brasier et al., 2011). Signal dependent binding of NF-B in
conjunction with histone acetylation (Hargreaves et al., 2009; Zippo et al., 2009)
mediates the recruitment of BRD4 to the vicinity of gene promoters with the associated
activity of CDK9, which induces the release of paused polymerases (Ai et al., 2011). TNF
promoter ChIP revealed a rapid-transient recruitment of BRD4 within 30 minutes of LPS
stimulation, whereas occupancy of BRD4 at the IL1B promoter was less prominent
(Figure 54).
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Figure 53. Effect of various inhibitors on P-TEFb binding to IL1B and TNF in THP-1 cells.
Shown is a ChIP analysis of the P-TEFb binding in 1-hour stimulated THP-1 cells, pre-treated with the
transcription factor inhibitors MG132 (blue bars) and U0126 (yellow bars), as well as the elongation factor
P-TEFb inhibitor DRB (red bars). The data are indicative of at least 2 independent experiments.

Figure 54. The effect of inhibitors on BRD4 binding to IL1B and TNF in THP-1 cells.
Shown is the ChIP analysis for the kinetics of BRD4 binding to the IL1B and TNF gene promoters. The
time points for LPS treatments are indicated above. The inhibitors (MG132, U0126, and DRB) were
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applied 2 hours prior to the 1.5-hour LPS stimulations of the THP-1 cells. The data are indicative of at least
2 independent experiments.

My analysis revealed that binding of BRD4 to TNF is unaffected in DRB treated
cells (Figure 54). In agreement, only slight inhibition of P-TEFb association at the TNF
promoter was observed. In contrast, P-TEFb binding upon DRB treatment to IL1B was
significantly depleted (Figure 53). Consistent with these results, both transcription
(Figure 22, lower panels) and serine 2 CTD phosphorylation along the coding region
(Figure 55) were affected more significantly for IL1B than for TNF.

Figure 55. DRB differentially affects the S2P CTD Pol II occupancy on IL1B and TNF genes THP-1
cells.
Shown is a ChIP analysis of the S2P CTD Pol II occupancy in resting and 1-hour stimulated THP-1 cells.
THP-1 cells were also pre-treated with the elongation factor P-TEFb inhibitor DRB (red bars) for 2 hours
prior to LPS treatments.

I argue that the differential association of P-TEFb on promoters for these genes in
DRB treated cells is mediated by gene-specific BRD4 recruitment. P-TEFb recruitment to
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IL1B seems to be less dependent upon BRD4 than TNF. In contrast, inhibition of C/EBP
activation had a dramatic effect on P-TEFb binding to IL1B (Figure 53). This result
suggests a possible novel role for C/EBP as an adaptor mediating the recruitment of
P-TEFb to the IL1B promoter. As expected, only minor changes in P-TEFb occupancy at
the TNF promoter was observed in U0126 exposed cells.

Transcription Factor Mediated Looping Between the IL1B Distal Enhancer and
Promoter
Previous reports have identified distal far-upstream enhancers, positioned -3000
bp upstream from the TSS for human and -2200 for mouse, critical for robust IL1B
induction (Godambe et al., 1995; Shirakawa et al., 1993). Recent genome-wide studies in
murine macrophages demonstrated that LPS responsive enhancers have common features
marked by inducible p300 binding and H3K4me1 modification (Ghisletti et al., 2010;
Heinz et al., 2010). This analysis of H3K4me1 revealed significant enrichment of this
mark throughout the transcribed regions of IL1B and TNF, as well as at the -3000 bp
upstream IL1B enhancer (Figure 56).

Figure 56. H3K4me1 is present throughout IL1B and TNF in THP-1 cells.
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ChIP data revealing H3K4me1 spatial-temporal distribution along the IL1B and TNF loci in resting (black
line) 1 hour (red line) and 5 hour (green line) stimulated THP-1 cells. Averaged profiles derived from data
shown in Appendix G.

Chromosomal interactions between distal regulatory elements have been
implicated in regulating gene expression (Dekker, 2006). The dynamic association of
enhancers and promoters is often mediated by protein-protein and protein-DNA
interactions among transcription factors and chromatin modifiers, ultimately leading to an
enhanced transcription initiation (Deng et al., 2012). On the basis of in vitro studies,
functional cooperation between enhancer bound C/EBP and promoter bound Spi1 DNA
looping has previously been proposed as a mechanism for IL1B induction (Listman et al.,
2005; Yang et al., 2000). In collaboration with Dr. Kent Z.Q. Wang in our laboratory, I
used chromatin conformation capture (3C) to examine LPS-dependent in vivo long-range
chromosomal interactions between the IL1B enhancer and promoter. Figure 57B reveals
LPS-dependent physical association between the IL1B distal and proximal regulatory
elements.

A

B
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Figure 57. LPS induced chromatin looping regulates IL1B expression.
(A) Schematic representation of PCR primer pairs used for evaluating 3C ligation products. The four
primers used for 3C analysis are indicated as 1’, 2, 3’, and 4 in the diagram.
(B) 2% agarose gel was used for the PCR assessment of 3C ligation (restriction fragment) products from
resting, 1 hour stimulated, and inhibitor treated THP-1 cells. One hour stimulated THP-1 cells were pretreated with the indicated transcription factor inhibitors MG132 (NF-B inhibitor), U0126 (C/EBP
inhibitor) and additional C/EBP inhibitor SB 202190.
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The NF-B and C/EBP inhibitors abolished LPS dependent chromosome loop
formation (Figure 57B), transcription (Figure 44, 46, 47), nucleosome depletion (Figure
28), and Pol II recruitment to the IL1B promoter (Figure 58).

Figure 58. Effects of U0126 and MG132 on Pol II ChIP for IL1B and TNF.
Shown is the ChIP analysis for the spatial-temporal distribution of Pol II throughout the IL1B and TNF
genes. The time points for LPS treatments are indicated above. The inhibitors MG132 (NF-B inhibitor)
and U0126 (C/EBP inhibitor) were applied 2 hours prior to the 1 hour LPS stimulations of the THP-1
cells. The data are indicative of at least 2 independent experiments.

My data reveal that the chromosome looping correlates with the binding of
C/EBP to the enhancer and Spi1 to the promoter of Il1B. In addition to interacting with
C/EBP, the DNA binding domain of Spi1 was shown to physically associate in vitro
with NF-B (Nawarat Wara-aswapati and Philip E. Auron, unpublished data).
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These data suggest that endotoxin activation of both C/EBP and NF-B may
contribute to the dynamic juxtapositioning of the distal regulatory elements of IL1B by
common association with two critical Spi1 binding sites previously mapped to the IL1B
promoter (Kominato et al., 1995), resulting in the formation of a chromatin complex
favorable for gene induction.
Metabolic Effects on Transcriptional Regulation of Il1b and Tnf
Since P-TEFb recruitment to IL1B, in contrast to TNF, appears to be less
dependent upon BRD4 and more dependent upon C/EBP, other activation pathways for
P-TEFb activation, by release from the inhibited 7SK/HEXIM1 complex, were
considered. One of these is the possible involvement of PI3K/Akt, which has been
reported to directly phosphorylate and inactivate HEXIM1 on the HIV promoter
(Contreras et al., 2007). Figure 59 reveals that the PI3K inhibitor LY-294002 has a
greater effect on P-TEFb recruitment to Il1b than to Tnf in LPS-treated RAW264.7 cells.

Figure 59. The effect of PI3K inhibition on P-TEFb recruitment to Il1b in RAW264.7 cells.
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Shown is ChIP analysis of P-TEFb binding to Il1b and Tnf in the presence of the PI3K inhibitor LY294002 in RAW264.7 cells. The inhibitor LY-294002 was applied 1 hour prior to LPS stimulations.

Since increased synthesis of PI3K results in phosphorylation and activation of
Akt/PKB, which can counteract the inhibitory effect of AMPK (low ATP) on mTorc1, I
wondered whether there is a connection between Il1b gene activation and cellular
metabolism. The non-metabolizable glucose analogue and hexokinase inhibitor
2-deoxyglucose (2-DG) (Kang and Hwang, 2006) has been used to metabolically
challenge cells by directly inhibiting glycolysis and ATP synthesis. I observed
significantly higher levels of Pol II, S2P CTD, p-TEFb, and H3K36me3 on Tnf than on
Il1b for 2-DG treated BMDM (Figure 60). In contrast to Il1b, the levels of S5P CTD at
Tnf were not affected by 2DG. This is in agreement with experiments analyzing total Pol
II levels, in which Il1b is more affected by treatment with 2DG (Figure 60). These
results are consistent with a greater metabolic sensitivity for Il1b that may relate to the
distinct mechanism of P-TEFb activation. Interestingly, ligand-mediated activation of
both TLR and IL1R receptors not only induces IL1B transcription, but also directly
recruits and activates PI3K (Marmiroli et al., 1998; Sarkar et al., 2004), consistent with
the proposed role for PI3K/Akt in P-TEFb activated induction.
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Figure 60. Distinct metabolic sensitivity for transcription elongation on Il1b and Tnf in murine bone
marrow-derived monocytes.
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci were measured in resting
(black), 4h (light green) and 24h (light blue) LPS stimulated ex vivo-differentiated mouse BMDM.
Enrichment profiles for Pol II, PTEFb, S2P CTD Pol II, S5P CTD Pol II, and H3K36me3 are shown. The
BMDM were stimulated for indicated times with LPS ± 3 h pretreatment with 2-DG. The BMDM samples
were provided by Luke O’ Neill, Trinity Collage of Dublin, Ireland.
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HIF-1 plays an important role in regulation of the pro-inflammatory genes that
are activatied in the TLR4 stimulated macrophages (Tannahill and O'Neill, 2011). Our
analysis of the murine Ilib locus revealed a putative HRE element known to bind HIF-1
(Kimura et al., 2000), which is adjacent to a previously reported NF-B site (Hiscott et
al., 1993) (Figure 61).

Figure 61. A schematic representation of putative HIF1 binding site upstream of the il1b gene
promoter.
Our group has located a putative HIF1 response element (HRE) binding sequence in the vicinity of the
Il1b promoter, 360 bp upstream of the TSS. Shown is a comparison of human and mouse putative HIF-1
binding site (Blue). The NF-B binding site (red) is positioned further downstream in the mouse as
compared to a human IL1B. Additional experiments revealed that mutations in the HRE reduced the
expression of the IL1B-luciferase reporter (Tannahill GM, 2013).

ChIP analysis in BMDM revealed a delayed LPS inducible binding of HIF-1 to
the putative murine HRE. The most prominent binding of HIF-1 to this promoterproximal regulatory site is observed at 12 and 24 hours. This experiment is part of a
collaborative study that has additional evidence of HIF-1 involvement in Il1b gene
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regulation (Tannahill GM, 2013). Both 2DG and -KG reduced the HIF-1 binding to
the HRE (Figure 62). The Tlr4 gene was used as a positive control (Kim et al., 2010).
Our results reveal that HIF-1 is recruited to the Il1b promoter in LPS stimulated
BMDM.

Figure 62. HIF-1 is recruited to the Il1b and Tlr4 genes in LPS treated BMDM.
ChIP for HIF-1 binding to the Il1b and Tlr4 proposed binding sites was measured in resting 4h, 12h, and
24h LPS stimulated ex vivo-differentiated mouse BMDM. The BMDM were stimulated for indicated times
with LPS and/or pre-treated for 3h with the non-metabolizable glucose analogue and hexokinase inhibitor
2-deoxyglucose (2-DG) (Kang and Hwang, 2006), or the HIF1 inhibitor -ketoglutarate (-KG) (Gottlieb
and Tomlinson, 2005). The BMDM samples were provided by Luke O’ Neill, Trinity Collage of Dublin,
Ireland.

IL-1 Family members are coordinately expressed in LPS stimulated THP-1
monocytes.
Since IL1B is a member of a family of 11 genes (Dinarello, 2009), I have
investigated their LPS inducible expression in THP-1 monocytes. Our results reveal that
9 gene members are coordinately expressed with the transcription levels peaking at 2
115

hours post LPS treatment. Interestingly, IL1F6 is constitutively expressed and LPS
treatment dose not activate it. The expression of IL1F10 was not detected in THP-1 cells.
Since IL1B is potently expressed in THP-1 cells, additional qPCR plots were generated in
order to better resolve the kinetic expression pattern of the other inducible gene members
(Figure 63).
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Figure 63. Coordinate expression of the IL-1 gene family members.
Shown are kinetic qPCR data for the various IL-1 family members in LPS stimulated THP-1 cells. LPS
treatment time points are indicated. THP-1 cells were also pre-treated with the elongation factor P-TEFb
inhibitor DRB (red bars) for 2 hours prior to LPS treatments. Since the expression of IL1B is extremely
high, data presented in the bottom diagrams were re-scaled (100x, and 1000x) in order to visualize the
expression kinetics for the less abundant family members.
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DISCUSSION
The induction of pro-inflammatory IE genes IL1B and TNF involves stringently
regulated sequences of events triggered by TLR4 mediated detection of the LPS
component of bacterial cell walls. My detailed kinetic analyses of the mRNA profiles of
these immune genes provide novel insights into changes associated with their induction,
switch down and reactivation. I was able to recapitulate previous observations (Fenton et
al., 1988) demonstrating the expression pattern for IL1B and compare it to that of another
coordinately expressed IE gene, TNF. Temporal profiles of steady-state mRNA levels
revealed that both genes undergo a rapid transient induction, but differ in their
transcriptional shut down. While TNF fits the transient IE gene model and is completely
switched-off at 4 hours, elevated expression of IL1B continues for up to 24 hours poststimulation (Figure 6, 7). Because they code for potent inflammatory molecules,
posttranscriptional degradation serves as a means to prevent their uncontrolled
accumulation (Chen et al., 1994; Fenton et al., 1988). This explains the transient nature of
these genes and argues that the observed sustained expression for IL1B is due to
continuous transcription instead of message stabilization. Although IL1B sustained
expression is relatively decreased, it is physiologically significant due to the potent
biological activity of this cytokine (Dinarello, 2010) and the extremely high overall
transcription level (Webb et al., 1985). Additionally, analysis of steady state mRNA
levels in unstimulated THP-1 monocytes revealed the presence of low levels of unspliced TNF mRNA transcripts in comparison to undetectable IL1B. It has been
hypothesized that low levels of constitutive transcription for primary response genes
favors accessible chromatin and transcriptional competence important for their activation
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(Hargreaves et al., 2009). Previous reports indicate that activation of IE genes resides at
the level of pre-assembled components of transcription machinery at their promoters
(Adelman et al., 2009; Hargreaves et al., 2009). Engaged, but paused, Pol II complexes
and an euchromatic nucleosome architecture favors the immediate response to an
appropriate stimulus causing transition into a state of processive elongation (EscoubetLozach et al., 2011). Utilizing various molecular techniques I have analyzed the binding
of specific signal-responsive transcription factors, general factors involved in Pol II
regulation, and chromatin modifications in order to provide insights into mechanisms
influencing the observed distinct expression profiles of IL1B and TNF. Although both
mediators are classified as IE responders in TLR4-dependent stimulated cells, this study
using human and murine monocytes reveals transcriptional and epigenetic differences
during their expression cycle.

In unstimulated cells, the TNF promoter proximal region contains a significant
amount of pre-bound Pol II, which is consistent with studies in murine macrophages
(Adelman et al., 2009; Escoubet-Lozach et al., 2011; Hargreaves et al., 2009). A
collection of antibodies recognizing various modifications of the Pol II CTD was used to
characterize the nature of this pre-assembled Pol II complex. ChIP analysis revealed the
presence of S5P modified CTD co-localized with the observed total Pol II enrichment
peak (Figure 17), which indicates that the observed Pol II has initiated transcription
(Saunders et al., 2006), but paused nearly 57 bp beyond TSS. Additionally, I observed a
high level of pre-bound TBP, a component necessary for accurate transcription initiation
(Thomas and Chiang, 2006), at the expected TNF TATA box, further confirming the
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presence of suitably engaged Pol II. I hypothesize that the pre-assembled components of
the transcription machinery contribute to the low constitutive transcriptional leakiness of
the TNF gene, keeping it primed for rapid activation. Under basal conditions, quiescent
IL1B is more stringently regulated, containing only slight levels of Pol II engaged at the
promoter and minimal TBP binding. I hypothesized that a recruitment of Pol II
machinery to the IL1B promoter requires an additional step in the form of TLR4
dependent recruitment of effector proteins and/or changes in chromatin accessibility. LPS
stimulation triggered a transient increase of Pol II at the proposed TNF pause site as well
as throughout the body of the gene (corresponding to elongating Pol II), but the levels of
TBP did not significantly change. On the other hand, the induction of IL1B was primarily
dependent on de novo recruitment of Pol II complexes, which paused shortly after
resuming initiation in the vicinity of the TSS. As expected, binding of TBP paralleled the
LPS dependent increase of Pol II at the IL1B locus. These results suggest a presence of
two gene specific induction mechanisms with different rate-limiting properties. While the
rate-limiting step in IL1B activation depends on de novo recruitment of Pol II, TNF
induction is mediated by a release of existing promoter bound Pol II complexes. These
differences likely contribute to the observed transcriptional delay for IL1B as measured
by steady state mRNA and Pol II kinetic occupancy assays (Figure 8B). Analyses of
NELF occupancy, a factor potentiating Pol II stalling (Core and Lis, 2008), revealed high
binding levels at TNF in unstimulated cells followed by a decrease upon LPS treatment.
An observed decline of NELF following stimulus is consistent with LPS dependent
binding of P-TEFb, which induces phosphorylation of NELF (Gilmour, 2009) and
alleviates the paused Pol II, transitioning it to elongation. At 5 hours post stimulation,
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when message levels decline, P-TEFb is depleted from the promoter region and NELF
occupancy returns to original levels, likely explaining gene shut down. In contrast to
TNF, P-TEFb recruitment to IL1B is prolonged (although decreased) and present at 5
hours post stimulation. This provides a plausible explanation for the delayed/sustained
phase of IL1B expression as compared to that of TNF. The data argue for a kinetic
interplay between positive (P-TEFb) and negative (NELF) pausing factors that may
contribute to the differential post-induction decrease and shutdown of these two IE genes.
A presence of paused polymerase, as indicated by increased enrichment signal at
the promoter as compared to the structural gene, was detected at TNF and IL1B
promoters in LPS stimulated monocytes. Interestingly, two paused Pol II complexes were
detected at IL1B while only one primary complex was present at the TNF promoter
(Figure 11). Analysis of the RNA intermediates revealed that the first Pol II peak at both
genes was associated with short transcripts whose levels correlated with the temporal
binding of Pol II and were selectively sensitive to inhibitor treatments (Figure 22).
Global genome sequencing analysis revealed that such transcripts are actually nascent
RNA intermediates emerging from stalling polymerases (Churchman and Weissman,
2011). Detection of RNA intermediates was limited only to the regions beyond the TSS
of both genes, which further confirmed that the observed transcripts are specific to
processive polymerase, and not aberrant byproducts of cDNA synthesis. A total of five
antibodies (Pol II, S5P CTD Pol II, NELF and P-TEFb) from independent ChIP
experiments collectively revealed two pausing sites near the IL1B gene promoter. I
hypothesize that the second Pol II complex at the IL1B locus represents a second paused
polymerase. The progression of these complexes is delayed due to several plausible
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factors. Since nucleosomes have been indicated in posing as a physical barrier to
transcribing polymerases (Petesch and Lis, 2012), the presence of a downstream +1
positioned nucleosome might be responsible for halting Pol II movement. An additional
explanation for the Pol II resting can stem from the presence of a long 5’ untranslated
region (UTR) encompassing the first 505 bp of the IL1B gene. A recent study proposed a
“complex interaction” model between core promoter elements and initiating and paused
Pol II complexes, which can often accumulate at the intron-exon splicing junctions, as
well as upstream of nucleosomes (Kwak et al., 2013). Such gathering of Pol II enzymes
creates a dispersed Pol II enrichment signal at the transcription initiation site and beyond
the TSS (Kwak et al., 2013). These observations further support the possibility that the 5’
UTR and +1 nucleosome present at the IL1B dictate pausing for transcribing/elongating
Pol II. Additionally there are indications that the length of a 5’UTR can influence gene
expression levels (Cenik et al., 2010). Since mRNA splicing can occur cotranscriptionally (Goldstrohm et al., 2001), the augmented recruitment of splicing factors
to the vicinity of 5’UTR can play a potential role in slowing down Pol II progression. In
fact, studies suggest that a slower Pol II rate favors precise assembly of splicing factors
for propter intron removal (de la Mata et al., 2010). I speculate that the second Pol II
pause might serve as an additional regulatory checkpoint for ensuring proper IL1B
transcription elongation.

Here I show that LPS inducible binding of NF-B facilitates the recruitment of
BRD4 and the subsequent recruitment of P-TEFb to human TNF. My data revealed that
the inhibition of NF-B binding resulted in significant depletion of P-TEFb recruitment
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to both genes (Figure 53). This observation is consistent with reports indicating that NFB phosphorylated at Serine 276 interacts with the active P-TEFb complex consisting of
bromodomain protein 4 (BRD4) and cyclin-dependent kinase 9 (CDK9) (Brasier et al.,
2011). Signal dependent binding of NF-B in conjunction with histone acetylation
(Hargreaves et al., 2009; Zippo et al., 2009) mediates the recruitment of BRD4 to the
vicinity of gene promoters with the associated activity of CDK9, which induces the
release of paused polymerases (Ai et al., 2011). Accordingly, I detected a transient
recruitment of BRD4 to the TNF gene. ChIP enrichment for BRD4 at the IL1B promoter
was much less prominent (Figure 54), suggesting that P-TEFb is not brought to the IL1B
promoter independently of BRD4. Cell permeable inhibitor DRB was used in this study
to block action of P-TEFb and show that blockade of this factor causes freezing of Pol II
throughout the IL1B and TNF gene loci (Figure 17) and reduction of transcript
accumulation (Figure 22). In addition to selectively inhibiting CDK9 activity (Baumli et
al., 2010), DRB has been also shown to alleviate the inactive 7SK/HEXIM1 sequestered
P-TEFb to an active BRD4-bound state (Biglione et al., 2007; Nguyen et al., 2001; Yik et
al., 2003). In this way DRB increased recruitment of BRD4 and P-TEFb to the viral C
promoter in Burkitt’s lymphoma cell lines (Palermo et al., 2011). My analysis revealed
that binding of BRD4 to TNF is unaffected in DRB treated cells (Figure 54). In
agreement, only slight inhibition of P-TEFb association at the TNF promoter was
observed. In contrast, P-TEFb binding upon DRB treatment to IL1B was significantly
depleted (Figure 53). Consistent with these results, both transcription (Figure 22, lower
panels) and S2P CTD along the coding region

(Figure 55) were affected more

significantly for IL1B than for TNF. I argue that the differential association of P-TEFb on
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promoters for these genes in DRB treated cells is mediated by gene-specific BRD4
recruitment. The LPS inducible P-TEFb binding to IL1B seems to be less dependent upon
BRD4 than is TNF. In contrast, inhibition of C/EBP activation had a dramatic effect on
P-TEFb binding to IL1B (Figure 53). This result indicates a likely novel role for C/EBP
as an adaptor mediating the recruitment of P-TEFb to the IL1B promoter. As expected,
only minor changes in P-TEFb occupancy at the TNF promoter were observed in cells
depleted of active C/EBP by the usage of selective inhibitor U0126 (Figure 53).
Additionally, I argue that PI3K/Akt mediated rescue of P-TEFb from inhibitory
7SK/HEXIM1 complex can selectively contribute to the elongation state of Il1b in
murine macrophages (Figure 59). Since it has been shown that a metabolic imbalance of
cells affects the PI3K/Akt transduction pathway, a disruption of glucose availability in
stimulated BMDMs caused selective inhibition of Il1b transcription as compared to TNF,
as shown in Figure 60.
Macrophage metabolism plays an important role regulating transcriptional control
of pro-inflammatory cytokines (Murdoch et al., 2005). My collaborative work with the
laboratory of Professor Luke O’Neill using murine macrophages revealed a novel role of
the oxygen sensing effector protein HIF1 in controlling Il1b transcription. Our group
has located a putative HIF1 response element (HRE) binding sequence in the vicinity of
the Il1b promoter, 360 bp upstream of the TSS (Tannahill GM, 2013). TLR4 dependent
stimulation of macrophages caused HIF1 binding to the HRE at 4 h with increasing
levels by 24 hours (Figure 62). The functional role of HIF1 was further established by
the addition of cell permeable -KG, which abolished its LPS mediated recruitment to
Il1b. It was shown that -KG induces HIF1 degradation (Gottlieb and Tomlinson,
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2005) and prevents its nuclear translocation. Additionally, treatment of cells with the
non-metabolizable glucose analogue 2DG (Kang and Hwang, 2006) also prevented
HIF1 binding. I postulate that 2DG mediated disruption of macrophage metabolism and
down-regulated activity of HIF1, leading to decreased Il1b expression. The Tnf gene
was not susceptible to 2DG treatment, as revealed by mRNA and Pol II ChIP analysis
(Figure 62). My kinetic ChIP analysis suggests that HIF1 recruitment to Il1b is delayed
and follows the binding of the rapidly induced factors NF-B and C/EBP. I speculate
that HIF1 plays a role in mediating the sustained phase of il1b expression. This is
distinct from Tnf, which lacks a putative HRE in the vicinity of its promoter. Figure 64
summarizes the key observations and differences in the regulation of the il1b and tnf gene
transcription.
Previous reports argued that il1b and tnf genes are refractory to reactivation due to
a plethora of intrinsic immuno-protective mechanisms commonly recognized as
endotoxin tolerance (Chan et al., 2005; Foster and Medzhitov, 2009). Endotoxin
tolerance results in a decreased responsiveness of certain rapidly-induced monocyte
genes to repeated LPS stimulation. In agreement with the previous studies, our data
indicate that once activated, TNF cannot be re-expressed upon secondary stimulation
(Figure 7). In addition, the reduced responsiveness of TNF cannot be reversed with
increased concentration of LPS used for subsequent reactivation (Figure 13). Prior
attempts to explain this phenomenon by transcription suppression have failed to note that
expression profiles for these genes are highly transient. If transcription following
secondary stimulation is not analyzed within a short time frame, the re-stimulation
properties can be overlooked. The endotoxin tolerance study by Foster et al., (Hargreaves
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et al., 2009) used ten-fold less secondary LPS stimulant than the primary dose. I argue
that the usage of inconsistent doses of secondary LPS throughout the studies skews the
experimental results. In my reactivation experiments, cell cultures were re-stimulated
with an equal dose of secondary LPS.
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Figure 64. Metabolic and TLR4 dependent pathways differentially regulate transcription of il1b and
tnf. Several findings of this work are represented in this figure. Depicted are LPS sensing TLR4 pathways
leading to activation, nuclear translocation and DNA binding of the transcription factors NF-B and
C/EBP. While the induction of TNF is primarily dependent on NF-B, IL1B requires both, NF-B and
C/EBP for its proper activation. This figure illustrates the connections between the metabolic pathways
and the regulation of HIF1 stability. Hypoxia, LPS treatments, and various metabolites affect the presence
of HIF1 in cells. These conditions inhibit the action of the enzyme prolyl hydroxylase (PHD), which
causes the ubiquitin-mediated degradation of HIF-1. Stabilized HIF-1 translocates into nucleus where it
binds to the hypoxia-response element located upstream of il1b.
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In addition, the washing of cells between primary and secondary endotoxin
challenge may result in experimental variability and induce physiological stress to the
highly sensitive cells. Here I show that the washing of cells caused dramatic reduction of
IL1B expression (Figure 27). In contrast, IL1B transcription is not desensitized in unwashed cell cultures (Figure 7, 13). This indicates that secondary LPS addition after
washing cells is ineffective and does not properly activate the transduction pathway
leading to transcriptional induction of IL1B. I hypothesize that washing cells with PBS or
media lacking fetal bovine serum (FBS) prior to secondary challenge may deprive the
cells of important soluble components such as LPS-binding protein (LPB) and CD14 that
are vital for proper TLR4 signaling (Aderem and Ulevitch, 2000).
My data provide evidence that IE gene promoters contained paused pol II
complexes after their initial transient transcription burst for up to 25 hours. This work
reveals that upon secondary stimulation, P-TEFb is re-recruited to the IL1B promoter,
resulting in the resumption and maintenance of transcriptional elongation by Pol II. This
is in contrast to tolerized TNF, in which secondary recruitment of P-TEFb and S2P are
absent (Figure 24, 25). As described in the introduction, P-TEFb mediated
phosphorylation of serine 2 within the CTD of elongating Pol II promotes recruitment of
various splicing factors to ensure proper nascent mRNA processing (Buratowski, 2003;
Egloff and Murphy, 2008). The fact that P-TEFb is recruited to IL1B and not TNF during
secondary LPS exposures, prompted me to examine the integrity of transcripts produced
in reactivated THP-1 cells. The analysis of a random primer (instead of polyA) generated
cDNA products, which revealed a minor increase of TNF mRNA in secondary stimulated
monocytes (Figure 26). These messages likely represent incompletely processed primary
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TNF transcripts that are generated by the low levels of P-TEFb-deficient transcribing Pol
II. I propose that the gene specific recruitment of P-TEFb serves as a regulatory step
mediating the escape form endotoxin tolerance. This mechanism ensures proper IL1B
mRNA polyadenylation and processing, which is deficient during the re-stimulation of
the TNF gene. My results indicate that the low levels of sustained IL1B expression may
maintain the gene sufficiently competent for secondary re-induction. Collectively my
mRNA and protein analyses argue that secondary induction of IL1B is a physiologically
significant phenomenon that further distinguishes it from TNF.
Nucleosome positioning is intimately linked to gene regulation by controlling the
accessibility of gene promoter sequences (Bai and Morozov, 2010). I have mapped the
nucleosome distribution (as measured by the spatial distribution of the nucleosome core
protein histone 3) in the vicinity of the promoter proximal regions as well as the temporal
changes associated with their LPS inducible evictions and differential re-assembly at the
end of the transient vs. sustained phase of TNF and IL1B transcription, respectively. My
data reveal a cell type specific NFR located upstream of the strongly phased +1
nucleosome at both genes (Figure 28). Analysis of HEK 293 cells, which do not
transcribe IL1B, revealed the presence of a highly phased -1 nucleosome within the NFR
that was also prominent in the inhibitor treated THP-1 cells (Figure 28). Transfection of
Spi1 with IRF8 and TRAF6 (acting as an LPS surrogate) induces displacement of this -1
nucleosome. I hypothesize that this highly transiently positioned nucleosome serves as a
control checkpoint mediating a cell type and stimulus selective accession of transcription
machinery to the IL1B core promoter elements. Inhibition of transcription factor
activation/recruitment to gene promoters in THP-1 cells similarly abolished LPS induced
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nucleosome clearance in a gene specific manner (Figure 58). While the inhibition of NFB had a pronounced effect on both IL1B and TNF, C/EBP inhibition only affected
nucleosomes on the IL1B promoter (Figure 58). This data provides a functional link
between transcription factor activation and nucleosome clearance from these LPSinduced IE promoters. A temporary clash between the -1 nucleosome and Pol II binding
could be responsible for the quiescent behavior of IL1B prior to its induction,
contributing to the observed transcriptional delay, as shown by Pol II ChIP and mRNA
kinetic studies (Figure 12).

Spatial-temporal analysis of the chromatin modifications

throughout the TNF and IL1B IE gene loci reveal monocyte-specific presence of low
levels of active marks such as H3K4me3 and H3K9ac in unstimulated cells. To my
surprise these marks did not significantly increase in 1 hour stimulated cells but
significant elevation in their enrichment was observed during the switch off of the genes
(Figure 30, 33). I argue that high levels of transcribing polymerases impede nucleosome
deposition and modification throughout the structural part of the genes. At the end of the
transient transcription burst, nucleosomes are re-deposited into their original positions
and become subject to histone modifiers. Strikingly, my results revealed an opposite
pattern for H3K9me1 levels distributed throughout IL1B and TNF in resting monocytes.
This mark was high in resting cells, but rapidly lost following LPS treatment and
remained low even during transcriptional shut-down. A methylated H3K9 commonly
associated with repressive heterochromatin, was shown to play a role in repression of
selected inflammatory genes in monocytes (Kouzarides, 2007; Saccani and Natoli, 2002).
Although the antibody used in the study by Saccani and Natoli was not specific enough to
distinguish mono-, di-, or tri-methylated lysine at H3, based on the spatial distribution of
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H3K9me1 in IL1B non-expressing cell lines (Figure 33), the H3K9me1 can likely be the
methylated form inducing a facultative heterochromatin. I observed that LPS replaced
repressive H3K9Me1 marks with transcriptionally permissive acetylation, likely
contributing to the enhanced gene expression of IL1B and TNF (Gomes and Espinosa,
2010). It is possible that monocytes package the IL1B and TNF genes with H3K9Me1 to
form repressed, but poised, chromatin conformations for keeping these IE genes from
exhibiting high transcriptional activity. The inhibitory mark H3K27me3 was virtually
absent from the gene loci, but its level was increased in cell types that do not transcribe
these IE genes (Figure 30, 33). TNF in Hut 102 cells reveals significant levels of both
H3K4me3 and H3K27me3, the so-called “bivalent” mark (Akkers et al., 2009), indicative
of developmental, rather than transient IE induction, possibly responsible for the
constitutive expression of this gene in these HTLV-1 infected malignant T cells (Figure
30, 33). HEK293 cells do not show positive indicators for either gene, exhibiting nonbivalent inhibitory H3K27me3 on both. The inhibitory H3K27me3 extends throughout
the entirety of both genes, but appears to be more focused over the coding region of TNF.
In contrast, IL1B reveals a greater level of H3K27me3 far upstream over the potent LPS
enhancer near -3000, which binds C/EBP (Shirakawa et al., 1993) (Figure 30, 33). The
suppressive effect of the polycomb group proteins mediated by H3K27me3 directed
transcriptional silencing is reversed by the H3K27 specific demethylase JMJD3 during
macrophage inflammatory responses (De Santa et al., 2007). Loss of this repressive
chromatin mark in Drosophila and embryonic stem cells, was shown to result in an
increase in H3K27 acetylation, which was mediated by the histone acetyltransferase
(HAT) activity of p300 and CBP (Pasini et al., 2010; Tie et al., 2009). My observations
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of depleted levels of H3K27Me3 in THP-1 cells encouraged us to examine the kinetic
changes in H3K27Ac deposition and binding patterns of p300 on IL1B and TNF. As
revealed in Figure 31, acetylation at lysine 27 was associated with LPS-dependent
increase at the -2 nucleosomes, while, transient decrease in H3K27Ac on downstream
nucleosomes was observed. In agreement with these changes, p300 was transiently
recruited upstream of IL1B and TNF promoters by LPS (Figure 32).
My data reveal that the cell type restricted expression of IL1B is due to the
presence of the monocyte-specific differentiation factor Spi1/PU.1 (Spi1), which binds
constitutively to the IL1B promoter and enhancer in resting THP-1 (Figure 34) and
poises the gene for induction. The question of macrophage and B-cell restricted gene
regulation was addressed in previous studies that revealed that Spi1 binding corresponded
to nucleosome depleted regions and mediated local deposition of H3K4me1 as novel LPS
inducible enhancer mark (Ghisletti et al., 2010; Heinz et al., 2010). Additionally my data
show that Spi1 plays a critical role in poising and proper activation of the IL1B gene
promoter. As a pioneer factor, Spi1 may have a unique capability of binding a properly
oriented nucleosome wrapped DNA (Ghisletti et al., 2010; Smale, 2010). I provided
evidence that ectopic expression of Spi1 facilitated the recruitment of TBP via its Nterminal binding domain (Figure 41, 42). In resting monocyes the IL1B core promoter
was depleted of nucleosomes, but TBP recruitment was evident only upon LPS activation
(Figure 41). I postulate that the binding of Spi1 is necessary, but insufficient, for LPSmediated induction in THP-1 cells, as well as in HEK293 cells for which Spi1 in the
absence of surrogate stimulation (co-expression of IRF8 and TRAF6) does not cause
strong nucleosome clearance (Figure 42). I hypothesize that stimulation-dependent
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binding of NF-B and C/EBP to the DNA loop-mediated proximity of constitutively
bound Spi1, facilitates induction of IL1B via nucleosome remodeling. Both of these
factors bind transiently to specific promoter sites and cooperatively regulate the Pol II
dynamics at this gene (Figure 43, 45, 58). The Spi1-mediated nucleosome eviction is
especially true for the -1 nucleosome, which appears to occlude TSS-proximal binding of
TBP (Figure 28, 42). This contrasts with TNF, in which the -1 nucleosome resides
further upstream, permitting TBP access (Figure 28). The mechanism by which this
occurs could depend upon the observed stimulation-dependent recruitment of p300
histone acetyltransferase (Figure 32) and the SNF2/BRG1 SWI/SNF chromatin
remodeling enzyme (Figure 29) by activated transcription factors. Both NF-B (Hottiger
et al., 1998; Tando et al., 2010) C/EBP (Kowenz-Leutz and Leutz, 1999; Mink et al.,
1997) as well as HIF-1 (Kenneth et al., 2009) have been reported to directly recruit both
SWI/SNF remodelers and p300 histone acetyltransferases. This would enable the
nucleosome clearance required for Spi1-assisted recruitment of TBP to TATA box DNA.
Regardless, as suggested by ectopic expression in HEK293 cells (Figure 42),
nucleosome remodeling depends upon the integrity of the Spi1 N-terminal domain in
concert with the activation of transcription factors, and appears to be necessary for TBP
recruitment. These cooperative associations likely facilitate the subsequent assembly of
the paused Pol II complex and regulate its release by P-TEFb in order to transition into
productive transcription elongation. The presence of highly paused and rapidly
transcribed Pol II further enhances the open promoter by competing with nucleosome redeposition (Core and Lis, 2009).
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Additionally, it was postulated that CK2 kinase may play a role as an LPS
inducible switch for Spi1 bound at the IL1B enhancer mediating IRF4 recruitment and
facilitating gene expression (Liang et al., 2006). In search of a mechanism for Spi1
activation, I hypothesized that CK2 can potentially act as an LPS dependent Spi1
activator mediating recruitment of TBP. My ChIP analyses did not reveal the presence of
LPS induced CK2 binding to the IL1B promoter. On the other hand, Spi1-mediated TBP
recruitment can be suppressed by an inhibitory factor in unstimulated monocytes. For
example, Translocated in liposarcoma (TLS), an RNA binding protein was shown to bind
Spi1 in vivo and suppress its transcriptional activity (Hallier et al., 1998). RNA binding
properties of TLS were also associated with noncoding RNA (ncRNA) mediated
CBP/p300 inhibition and transcriptional repression of CCDN1 gene upon DNA damage
signals (Wang et al., 2008). I speculate a potential role for TLS or a similar inhibitory
factor acting as a repressive control switch at the IL1B promoter that is alleviated in a
TLR4 dependent manner. Interestingly a preliminary screen for LPS induced non-coding
RNA in THP-1 cells has revealed a candidate ncRNA with TLS binding site (J. Adamik,
unpublished data) located at approximately -300 bp upstream of the IL1B TSS. Figure
65 depicts a model for Spi1 mediated TBP recruitment as well as the recruitment of two
paused complexes to IL1B gene.
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Figure 65. Model depicting a possible spatial configuration for the IL1B promoter sequence (Courtesy
of Philip E. Auron).
The model is derived from the published X-ray structures using coordinates provide by the RCSB Protein
Data Bank (PDB): Spi1 DNA binding ETS domain (1PUE) (Kodandapani, R., et al., 1996); TBP (1YTB)
(Kim, J.L., et al, 1993); and Pol II (1EN0) (Gnatt et al., 2001) DNA complexes. The PDB coordinates for
the above structures were positioned as independent DNA complexes in pseudo 3D-space, connected by
appropriate lengths (Kominato et al., 1995) of B-form DNA in accordance with the theoretical interaction
reported for the association of Pol II with TBP (Bushnell et al., 2004) using RasMac 2.7.3 molecular
graphics visualization software. The location and nature of the cartoon extension representing the amino,
extra-ETS domain, regions of the Spi1 transactivation region is positioned in contact with TBP, as
supported by an earlier report (Hagemeier et al., 1993).
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Finally I show, that the orchestrated recruitment of transcription factors to the
IL1B enhancer and promoter mediate their proximal chromosomal interactions (Figure
57). Since NF-B and C/EBP are necessary for induction of the chromatin loop and
were shown to physically associate with Spi1 (Nawarat Wara-aswapati and Philip E.
Auron, unpublished data) (Listman et al., 2005), I postulate that such interactions may
mediate activation of Spi1 leading to recruitment of TBP and Pol II, resulting in gene
transcription. Interestingly, the 3C results demonstrating the existence of a chromatin
loop, consistently revealed the prevalence of one PCR product in unstimulated
monocytes. This PCR band, which represents a primary recombination product in
unstimulated monocytes, suggests the possibility of a preferred conformational proximity
for the upstream and downstream IL1B sequences prior to LPS induction (Figure 57).
Such preformed chromatin architecture has been observed for cells at specific
developmental stages (Meaburn and Misteli, 2007).
Analysis of the temporal expression patterns of the IL-1 family genes revealed
LPS inducible coordinate expression for several members (Figure 63).

The most

abundantly expressed member of the cytokine family in the THP-1 cells is IL1B. IL1A,
IL1RN, IL18, and IL33 are expressed with similar kinetics, but their expression is weaker.
The last group of genes including: IL1F7, IL1F9, IL1F8, and IL1F5 also correspond to
the LPS inducible expression pattern with the weakest detection level. I did not detect
expression of IL1F10 in LPS stimulated THP-1 monocytes. Interestingly, IL1F6 was
constitutively expressed and its expression was actually down regulated with LPS
treatment. A significant level of constitutive expression was also detected for the
members: IL1RN, IL18, and ILF7. Strikingly DRB treatment abolished the expression of
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all the members suggesting that they are transcribed by paused polymerases and that
P-TEFb recruitment serves as an important regulatory step during their activation.
Members that were constitutively active were reduced to a lesser degree when treated
with DRB. This suggests that some of their accumulated transcripts produced in resting
cells were present even though their LPS inducible transcription was halted due to the
lack of active P-TEFb. The eukaryotic nucleus is organized into distinct transcriptional
units that contain preformed Pol II machineries called “transcription factories”. These
clusters of transcription complexes and coactivators bound to gene regulatory regions are
tethered via DNA loops and are able to efficiently coordinate the transcription of several
gene units (Cook, 2010; Papantonis and Cook, 2010). Since the IL-1 family members are
transcribed with similar kinetics, and most of them are located on the same chromosome,
it is possible that they are part of a larger 3D transcription unit. I speculate that the 3kb
chromatin loop observed for the IL1B promoter and enhancer might be part of a higher
order clustered gene family conformation. The paused polymerases present at the
promoters might likely facilitate the assembly of chromatin domains that bring the gene
members into proximity.
In summary, IL1B and TNF differ in the initial state of their promoters in
unstimulated cells. Strikingly, during maximal initial expression (1 h) the chromatin
architecture of the two genes looks quite similar. However, at later times (5 h) distinct
new architectures are established, resulting in the tolerizing of TNF. Importantly, I
observe that the IL1B and TNF genes, although both dependent upon the activation of
NF-B, reveal numerous distinctions (Figure 66) that may be reflective of the known
differences that exist for the cell source range and functions of their gene products. IL-1
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expression is known to be more restricted to monocytes than is TNF (Kronke et al.,
1988), likely dependent upon the requirement for Spi1. The distinct functions of the two
proteins is supported by the recent advent of specific therapeutic blockers, which reveal
that there are various diseases in which protein blockade results in asymmetric efficacy,
and occasionally asymmetric contraindication (Argiles et al., 2011; Dinarello, 2011a, b).
Consequently, it is reasonable that such functional differences might require a degree of
differential regulation for two similar, but non-identical immune effectors.
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Figure 66. Proposed Mechanism for LPS mediated induction of IL1B and TNF in monocytes
(Courtesy of Philip E. Auron).
(A) Summary of ChIP kinetics for some key features of IL1B and TNF in THP-1 monocytes. Pol II, TBP
and Spi1 are as indicated. Histone modifications at specific locations detailed in the text are labeled. Key
nucleosomes are designated by position relative to the TSS (-2, -1, +1). (B) Models for IL1B and TNF gene
regulation. Red text highlights important distinctions between the two genes along the induction kinetic.
Nucleosomes are marked with stars (acetylation) and spheres (trimethylation) representative of significant
increases in modification. Darkly colored nucleosomes are phased and likely to be less dynamic, and
suggestive of impediments to gene expression. The indicated locations of Pol II are represented by various
levels of intensity, reflecting the relative degree of proposed dwelling on DNA. Arrowheads on Pol II
represent the relative efficiency of elongation, as indicated by the length of the associated dotted line.
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SUMMARY OF NOVEL FINDINGS AND FUTURE STUDIES
This dissertation significantly contributes to the understanding of immediate early
(IE) gene induction for two important Toll-like receptor 4 (TLR4)-dependent genes
coding for TNF and IL-1. The study of these two immune mediators can be applied to
variety of other stimulus dependent immune and developmental genes. IE genes are
almost instantaneously induced in response to extracellular signaling events due to gene
poising, a process that is thought to involve a paused, pre-recruited, RNA polymerase
(Pol II). I have investigated the mechanisms of endotoxin induction, shutdown and
endotoxin tolerance for these genes. This study reveals major distinctions that correlate
with the transcription factor requirement, dynamics of Pol II pausing, nucleosomal
promoter architecture, and epigenetic signatures. The kinetic approach used in this study
focuses on the resting state, prompt transcription, and transient shut down, providing a
novel understanding of the temporal resolution of IE gene regulation. An additional issue
relates to the study of endotoxin tolerance, the phenomenon of desensitization of a TLR4
signal following recent prior signaling. Here I show that the IE genes have low levels of
paused polymerases for up to 24 hours post-stimulation even though their transcription is
absent or minimal. Upon subsequent LPS exposure, the tolerized TNF gene remains in a
paused state, while the IL1B gene resumes additional transcription due to influence of the
a positive elongation kinase P-TEFb. This work presents novel connections between
macrophage metabolism and the regulation of pro-inflammatory genes. My additional
collaborative study in murine macrophages revealed a novel role for the oxygen sensing
effector protein HIF1 in controlling Il1b transcription. The genes coding for TNF and
IL-1 have long been associated with the activation of the NF-B transcription factor,
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which is important for vigorous expression. As a consequence of this dependence and
similar expression kinetics, the assumption has been that these genes are similarly
regulated. I have observed that in contrast to TNF, IL1B is continually expressed for long
periods and is significantly less susceptible to the phenomenon of endotoxin tolerance,
while being more sensitive to the metabolic state of the cell. My study shows that
although I observe pre-induced TNF to behave as what is now classically referred to as a
poised gene, by virtue of the presence of a paused pre-recruited RNA polymerase (Pol II)
and TATA binding protein (TBP), the resting IL1B gene is generally devoid of TBP and
Pol II. Therefore, IL1B appears to behave as a poised IE gene in the absence of the
hallmarks that have been suggested to be critical for immediate early induction. I provide
novel results demonstrating that complete NF-B inhibition decreases, but does not
completely eliminate, IL1B transcription, supporting the involvement of other factors
which may play a critical role in regulating this potent gene. These include C/EBP for
the IL-1 gene (IL1B), and the realization that the various new specific therapeutic
blockers of TNF and IL-1 often generate distinct asymmetric effects and
contraindications, supporting evidence in favor of distinct roles and mechanisms for these
molecules in homeostasis and disease. My C/EBP and NF-B inhibition experiments
suggest a distinct functional linkage between the transcription factors and the recruitment
of Pol II machinery as well as the P-TEFb to these IE genes. A detailed analysis of the
spatial-temporal distribution of chromatin marks in resting monocytes reveals that
epigenetic modifications such as H3K4me3 and H3K9ac often resemble chromatin
patterns of an actively transcribed gene as compared to non-monocytic cell lines. Here I
provide new evidence that the differential gene shutdown observed between the two IE
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genes is reflected by the nature of their chromatin modifications following the initial
phase of rapid-transient transcription. My results extend beyond the previously reported
Spi-1/Pu.1-mediated opening of pro-inflammatory gene enhancers and suggest a novel
role for this pioneer factor at selected IE gene promoters. The findings of this work
provide a new model for IL1B gene activation, which involves an inducible
enhanceosome-like chromosomal looping and dynamic nucleosome transactions
mediated by inducible transcription factor interactions.
Since the mechanisms associated with IL1B and TNF gene regulation are highly
dynamic and complex, several unanswered questions remain to be determined. As
hypothesized in the discussion, the mechanism responsible for the IE nature of the IL1B
gene is intriguing because this functionally “poised” gene fails to exhibit the classic
hallmark of a significant amount of pre-bound/paused Pol II, as has been suggested by
others (Gilchrist et al., 2008; Guenther et al., 2007; Kininis et al., 2009; Muse et al.,
2007; Rahl et al., 2010; Zeitlinger et al., 2007). However, many aspects of the IL1B
promoter such as nucleosome phasing, constitutive transcription factor assembly, and the
transcriptionally permissive chromatin marks suggest that the promoter is competent for
Pol II recruitment. Yet, one striking difference is the relatively low level of pre-recruited
TBP. In this way, IL1B does not fit the model of an IE gene. One possible explanation is
that the IL1B promoter is repressed in a way that prevents its basal transcription, perhaps
inhibiting TBP recruitment by Spi1. Studies of the CCND1 gene, which codes for cyclin
D1, revealed that its expression is down-regulated by an upstream series of inhibitory
ncRNA. By associating with the TLS (translocated in liposarcoma) protein, ncRNA
mediates inhibition of p300 histone acetyltransferase activity leading to gene shut down
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(Wang et al., 2008). Interestingly, my preliminary examination of the IL1B locus revealed
a TLS consensus binding sequence approximately 300 bp upstream of the IL1B promoter.
An initial screening using non-quantitative PCR revealed the existence of several LPSdependent upstream transcripts, one of which contained the TLS consensus. A kinetic
ChIP, targeting TLS in resting and LPS treated monocytes could provide an indication of
its connection to the expressed ncRNA. If a correlation is observed, siRNA mediated
inhibition of TLS can be performed in order to reverse the potential repressive effects
associated with its association with the IL1B promoter. Additionally, one could design
antisense probes (shRNA) to target potential ncRNA, potentially abolishing any ncRNA
inhibitory effect on IL1B in resting monocytes, observing whether this results a low level
of basal transcription and Pol II recruitment to the gene.
Another issue beyond the initial repression of IL1B is the mechanism responsible
for both its extended expression and re-induction (i.e., its resistance to endotoxin
tolerance). One possible model is that this process is dependent upon a distinct means of
late induction. An obvious candidate is the late LPS-dependent binding of HIF-1
(Figure 61). This could be approached by using inhibitors, such as -ketoglutarate or
HIF-1 siRNA to determine whether a reduction in HIF-1 can convert the induction
profile for IL1B into one similar to that exhibited by TNF.
The IL-1 family gene members are another topic that could be explored in more
detail. Since the preliminary mRNA study revealed a coordinate expression of these
genes (Figure 64), Pol II ChIP can be performed to further define the transcriptional
responsiveness of these genes. Additionally, a circularized chromatin conformation
capture (4C) (Simonis et al., 2007), which can capture numerous long-range interactions,
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could be a valuable tool to assess physical chromatin associations at the 180 kbp IL-1
gene family locus on human chromosome 2.
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APPENDICES

Appendix A. Comparison of IL1B and TNF Transcription in Monocytes
Steady-state mRNA kinetics for IL1B and TNF transcripts in LPS stimulated THP-1, RAW264.7, and
hPBMCs. Transcript levels were normalized to beta 2-microtubulin (B2M), and then as ratio of amount in
resting vs. LPS-treated cells. The mRNA dlevels for primary LPS challenge are represented as black bars.
White bars show transcript levels following re-stimulation.
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Appendix B. Pol II occupancy at the il1b and tnf loci.
Pol II ChIP throughout the IL1B and TNF loci in resting (black bars), 1h (red bars), and 5h (yellow bars)
LPS stimulated THP-1, RAW264.7, and hPBMC cells. Vertical gray bars locate the positions of important
gene landmarks. Numbers at the bottom of the figures denote positions relative to the TSS. These include
TATA box and the canonical Pol II pause position (approximately 30 bp upstream and 50 bp downsteam of
TSS, respectively).
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Appendix C. Distribution of factors relevant to differential transcriptional regulation.
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ChIP for factors related to Pol II initiation and elongation at IL1B and TNF loci in THP-1 cells were
measured at distinct time points in resting (black bars), 1h (red bars) and 5h (yellow bars) LPS stimulated
THP-1 cells. Enrichment profiles for TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and Pol II
(using alternative 8WG16 antibody) are shown. A purple bars in the 8WG16 (bottom panels) experiment
represents a 1-hour time point, in which THP-1 cells were pre-treated with the P-TEFb inhibitor 5,6dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS.
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Appendix D. Average profiles of factors relevant to differential transcriptional regulation in LPStreated RAW264.7 cells.
ChIP for factors related to Pol II initiation and elongation at Il1b and Tnf loci in RAW264.7 cells were
measured at distinct time points in resting (black bars), 1h (red bars) and 5h (yellow bars) LPS stimulated
THP-1, cells. Enrichment profiles for Pol II, TBP, S5P CTD Pol II, S2P CTD Pol II, NELF, P-TEFb and
Pol II (using alternative 8WG16 antibody) are shown. A purple dotted line in the 8WG16 (bottom panels)
experiment represents a 1-hour time point, in which RAW264.7 cells were pre-treated with the P-TEFb
inhibitor 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazol (DRB) prior to stimulation with LPS.
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Appendix E. ChIP re-stimulation experiments at 25 hours.
ChIP for S2P CTD Pol II, NELF, P-TEFb, and Pol II at the IL1B and TNF during secondary LPS
stimulation of THP-1 cells. The white and gray bars denote ChIP data for primary LPS challenge harvested
at 13 and 25 hours post simulation respectively. The pink and light green bars show ChIP data for THP-1
cells that were initially treated for 13 and 24 hours respectively with LPS, and subjected to a re-stimulation
for an hour prior to their fixation and harvest. Equal dosage of LPS (1 g/ml) was used in both, primary
and secondary stimulation experiments.
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Appendix F. Nucleosome positioning dynamics during IL1B and TNF induction.
In the top panels are depicted spatial and kinetic histone 3 (H3) ChIP data for IL1B and TNF in resting
(black bars), 1h (red bars), and 5h (yellow bars) stimulated THP-1 cells. The blue bars represent H3 ChIP
for THP-1 cells pre-treated with the NF-B inhibitor MG132 and the orange bars denote the U0126
(C/EBPβ inhibitor) treated THP-1 cell samples. The middle panels reveal H3 occupancy throughout the
IL1B and TNF in Hut102 and HEK293 cells. Bottom panel indicates H3 ChIP for 293 cells transfected with
indicated transcription factors.
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Appendix G. Summary of the histone modification ChIP profiles for IL1B and TNF in THP-1, HEK
293, Hut102, and MG63 cells.
Illustrated are the summary profiles comparing nucleosome modifications for resting (black bars), 1h (red
bars), and 5h (yellow bars) LPS-treated human THP-1 cells with untreated HEK293 pre-neuronal cells
(purple bars), Hut102 cutaneous T lymphocytes (light blue bars), and MG63 osteoblastic cells (orange
bars). Depicted are spatial and kinetic ChIP profiles for Pol II, H3K36me3, H3k4me3, H3K9ac, and
H3K27me3, H3K9me1, H3K27ac, and H3K4me1 for IL1B and TNF. All panels are similarly scaled with
respect to spatial distribution along each gene, permitting comparative localization.
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